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CHAPTER 1 
GENERAL INTRODUCTION 
Polynuclear aromatic hydrocarbons (PAH) are substances with 2 or 
more condensed benzene rings. PAH originate from incomplete 
combustion processes or pyrolysis of organic material. Some 
PAH, which are present in food, air and water are known 
carcinogens. Table 1.1 presents the environmental exposure to 
benzota)pyrene (b(a)p). 
TABLE 1.1 Estimation of daily exposure to benzot a)pyrene 
Food 
Water < 50 ng/1 
Air pollution 0-30 ng/m3 
Smoking 20 cigarettes 
1- 3 //g Fritz et al, 1971 
2-16 /jg Verhoeve & Compaan, 1980 
<0.5 //g Vaessen et al,1984 
0.05 μ<3 Obana et al, 1984 
0.05 //g Piet et al, 1974 
0.45 μ<3 Brasser, 1976 
0.4 μς Hoffman et al, 1978 
Daily intake 0.5-16 ¿/g 
Occupational exposure of PAH is of another magnitude. This 
report deals with the monitoring of occupational exposure to 
PAH. The group of PAH is restricted to the carcinogenic 
polyaromatic hydrocarbons, viz. the PAH with four or more 
aromatic rings. Molecular formulae of the eleven carcinogenic 
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PAH and pycene are given in figure 1.1. 
BENZOIbFLUORANTHENE PYRENE BENZ[.|ANTHRACENE 
BENZOf/FLUORANTHENE BENZOfftpLUOflANTHENE eENZO(«lPVREME 
OIBENZO|«,«|PYRENE ΟΙΒΕΝΖΟΙ.ί,.ΊΡΥΒΕΝΕ DIBeNZO(«,TPYRENE' 
Figure 1.1 Molecular structure of selected PAH 
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1.1 PAH IN THE WORK ENVIRONNENT 
The most important sources of occupational exposure to PAH are 
coal tars and derived products. Crude coal tar is a by-pcoduct 
of coke (and in former times gas) works. Crude coal tar is 
usually distilled and blends of distillation fractions are used 
for various purposes. The pollution of the work environment is 
generally assessed by air quality measurements. Owing to the 
complexity of the tar composition, coal tars or derived products 
in air are usually detected by the presence of the coal tar 
pitch volatiles (CTPV) or a single marker namely b(a)p. The 
CTPV is the benzene (ACGIH-method) or cyclohexane (NIOSH-method) 
soluble extract of filtered airborne particulates. in many 
countries the threshold limit value (TLV or MAC) is based on 
this method (table l.II). 
TABLE l.II Occupational exposure limits for coal tar exposure 
(CTPV, as the benzene-soluble fraction of total 
particulate matter or benzo[a]pyrene (B[a]P) or 
total PAH) in different countries 
Country 
Australia 
Belgium 
Finland 
Italy 
Norway 
The Netherlands 
Sweden 
Switzerland 
USA 
NIOSH 
OSHA 
ACGIH 
USSR 
Yugoslavia 
Substance 
CTPV 
CTPV 
в[а]р 
CTPV 
total PAH 
CTPV 
B[a]P 
CTPV 
CTPV 
CTPV 
CTPV 
B[a]P 
CTPV 
ExpO! sure lii 
200 
200 
10 
200 
40 
200 
5 
200 
100 
150 
200 
0 
200 
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A review of b(a)p exposure levels in the occupational 
environment was presented by Lindstedt & Sollenberg (1982). 
Swedish workplaces were ranged according to the degree of 
exposure (table l.III). 
TABLE l.III Benzo(a)pyrene exposure levels for different work-
places in Sweden1 
1. Very high b(a)p exposure (> 10 ¿ig/m3 ) 
- Gas and coke work (topside work) 
- Aluminium works (some jobs, e.g. pin setters, potmen, 
cranemen, etc) 
- Manufacturing of carbon electrodes 
(pitch bin workers, etc) 
- Handling of molten tar or pitch (roofing, paving, 
insulation coating, etc) 
- Chimney sweeping (from top) 
- Asphalting if asphalt is mixed with tar 
(some jobs) 
2. Fairly high b(a)p exposure (1-10 ¿/g/m' ) 
- Gas and coke works in general (nontopside work) 
- Blast furnaces 
- Steel works (some jobs) 
- Manufacturing of carbon electrodes (in general) 
- Aluminium works (in general) 
- Asphalting if asphalt is mixed with tar (in general) 
3. Moderate b(a)p exposure (0.1-1 μg/mг ) 
- Steel works (in general) 
- Foundries (some jobs) 
- Welding of rails on track 
- Manufacturing of Söderberg electrode paste 
4. Low b(a)p exposure (0.01-0.1 vq/m') 
- Automobile repair shops 
- Asphalt manufacturing (from petroleum) 
- Foundries (in general) 
- Construction of tunnels and rock chambers 
- Aluminium electrolysis halls with prebaked 
electrodes 
5. Very low b(a)p exposure (< 0.01 //g/m3 ) 
- Iron mines 
- Garages 
1
 Adapted from Lindstedt & Sollenberg, 1982. 
Blome & Baus (1983) presented an overview of b(a)p exposure 
levels in German (FRG) workplaces (table l.IV). 
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TABLE l.IV Benzol a)pyrene in the German work environment1 
very high (//g/m1) 
coke works (topside) 0.03- 10 
carbon electrode production 0.2 -600 
refractory brick production 0.07- 21.9 
optical industry <0.05- 19.7 
high 
iron and steel works <0.05- 6.8 
foundries <0.05- 2.5 
silicon carbide production <0.05- 5.9 
medium 
rolling-mill <0.05- 0.5 
low 
handling petroleum pitch <0.05 
handling carbon black <0.05 
1
 Adapted from Вlome & Baus, 1983 
Published measuring data of PAH in the work environment in the 
Netherlands are scarce. Table l.V lists the available reports. 
TABLE l.V Polycyclic aromatic hydrocarbons 
in the Dutch work environments. 
CTPV B[a)P 
mg/m' i/g/m' 
Coal tar distillation plant <2.8 (vd Ven & 
Nossent, 1983) 
Coke works 
top 0.91 (vd Riet, 1983) 
side 0.27 
Rijnmond (industrial area, 
ambient air concentration, 0.0002 (CBS, 1983) 
year weighted average) 
The main Dutch industries associated with considerable 
occupational (and environmental) pollution of PAH are: 
2 Carbon electrode plants 
2 Coke works 
1 Needle coke plant 
2 Aluminium producing plants 
1 Coal tar distillating plant 
1 Phosphor plant 
1 Silicium carbide plant 
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1 Iron and steel works 
More peripheral industries are: 
- wood preserving industry 
- soil decontamination of tar-contaminated soil 
- asphalt handling (ce-use of coal tar asphalt) 
- glassworks 
- foundries 
and peripheral exposures are associated with the production, 
handling and application of: 
- hot tar derived products 
- tar derived coatings 
- waste oil 
- exposure to exhaust gases (industrial + vehicle) 
- carbon black or carbon black derived materials 
Skin exposure may be considerable for coal tar and pitch 
workers, who wear few clothes because of the heat stress in 
those work environments. PAH were detected in the skin oil of 
roofers, at levels of 0.048-36 ¿/g for the 36 cm* sample area of 
the forehead; two non-exposed referents showed no detectable 
amount of PAH (Wolff et al, 1982). Workers' clothes and 
underwear were found to be contaminated with b(a)p in a pitch 
manufacturing plant. The concentrations of b(a)p in clothing 
increased with time despite frequent laundering. Dry cleaning 
was found to be more effective (Kandus et al, 1972; Jach & 
Masek, 1973). 
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1.2 CANCER IN HORKERS EXPOSED ТО PAH. 
Since it has been known for many years that coal tar, as well as 
some isolated PAH are carcinogens in experimental animals, many 
investigators have studied the cancer frequency of workers known 
to be exposed to coal tar or coal tar pitch volatiles (CTPV) in 
relatively high concentrations. Recently, the International 
Agency for Research on Cancer (IARC, 1983) stated that there is 
sufficient evidence that 11 PAH are carcinogenic to experimental 
animals (table l.VI). 
TABLE l.VI PAH of which sufficient evidence is known that these 
compounds are carcinogenic to experimental animals 
chemical name chem. abstr. services reg no. 
-
-
-
-
-
-
-
-
-
-
-
benz[a]anthracene 
benzo[b]fluoranthene 
benzolj]fluoranthene 
benzo[к]fluoranthene 
benzo[a]pyrene 
dibenz[a,h]anthracene 
dibenzo[a,e]pyrene 
dibenzo[a,h]pyrene 
dibenzo[a,i]pyrene 
dibenzo[a,1]pyrene 
indeno[l,2,3-cd]pyrene 
56-55-3 
205-99-2 
205-82-3 
207-08-9 
50-32-8 
53-70-3 
192-65-4 
189-64-0 
189-55-9 
191-30-0 
193-39-5 
No reports were available in which workers were exposed to 
isolated PAH. 
1.2.1 LUNG CANCER 
Excess of lung cancers was found in the British and Japanese gas 
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works (Doll et al, 1972, Rawai et al, 1967), in the American, 
Japanese and British coke works (Lloyd 1971, Redmond et al, 
1976, Sakabe et al, 1975, Mazumdar et al, 1975) and in the 
Russian, Canadian and American aluminium industry (Konstantinov 
et al, 1979a, 1979b, Gibbs 1979, 1985, Aluminium Ass 1977). An 
investigation of 2071 chimney sweeps showed an excess of lung 
cancer (Hogstedt et al, 1982). Metal workers exposed to coal 
tar pitch volatiles showed a two-fold excess of lung cancer 
(Silverstein et al, 1985). 
1.2.2 SKIN CANCER 
In the past, scrotum cancer cases have been reported from 
chimney sweeps (Pott 1775, Paget 1850). An excess of skin 
cancer was found in the Russian aluminium industry (Konstantinov 
et al, 1979a) and among workers handling hot pitch and asphalt 
(Hammond et al, 1976). 
1.2.3 BLADDER CANCER 
Many authors have found an increased incidence of bladder cancer 
among coke oven workers. Generally, it is the presence of 
2-naphthylamine and not the PAH that is held responsible for 
this particular type of cancer (Zorn 1966). 
- 8 -
1.2.4 CANCER OF THE GASTRO-INTESTINAL TRACT 
An increase of cancer of the gastro-intestinal tract was found 
in the American coke works and among workers handling pitch and 
asphalt (Redmond et al, 1976, Hammond et al, 1976). Excess 
malignant neoplasms of the stomach and oesophagus were found 
among aluminium reduction plant workers (Gibbs 19Θ5). Metal 
workers exposed to CTPV showed a two-fold excess of cancer of 
the digestive organs (Silverstein et al, 1985). 
1.2.5 OTHER TYPES OF CANCER 
Workers handling pitch and asphalt showed an increase of 
leukaemia (Hammond et al, 1976). A slight and non significant 
increased frequency of leukaemia was observed among aluminium 
industry workers (Aluminium Ass 1977). Metal workers exposed to 
CTPV showed a four-fold excess of leukaemia (Silverstein et al, 
1985). 
1.3 OTHER EFFECTS IN WORKERS EXPOSED TO PAH 
The other effects of PAH-containing coal tars and creosote on 
humans has been studied in occupational medicine. The majority 
of toxic effects concern the skin and eyes; skin effects include 
dermatitis, chronic tar dermatosis, tar or pitch warts, 
cutaneous phototoxicity and chronic melanosis, folliculitis and 
pitch acne. A review of these effects is given by the IARC 
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(1985). 
There are only a few studies of the effects of coal tar on other 
targets. Morando (I960) described workers exposed to hot tar 
with abnormal serum protein levels. Kapitulskii (1966) found 
that pitch-coke electrode manufacturers, who were highly exposed 
to pitch distillates and heat stress, showed a decline in 
muscular strength and an increase in the latent period of motor 
responses to sound over the course of a workshift. Birdwood 
(1938) described ocular damages in two gardeners who had worked 
with creosote. Jonas (1943) described depression, weakness, 
severe headache, slight confusion, vertigo, increased salivation 
and nausea in a small percentage of subjects, who developed 
burns from creosote. Dumber (1962) described headache, 
giddiness, nausea, vomiting and copious salivation in nearly all 
of the 120 workers who had sprayed warmed creosote. Nilsen et 
al (1984) found a significantly increased number of macrophages 
in the expectorates of coke oven workers compared with controls. 
A more than additive effect of smoking and exposure was 
observed. In a large epidemiological study, Doll et al (1972) 
showed a large excess of deaths from bronchitis observed among 
retort house workers in the 1940s. 
1.4 MONITORING OF OCCUPATIONAL EXPOSURE TO PAH 
In occupational hygiene, monitoring is a systematic continuous 
or repetitive health-related activity, designed to lead if 
necessary to corrective action (Berlin et al^ , 1984). In 
occupational health care environmental and biological monitoring 
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are applied in the assessment of workplace agents to evaluate 
exposure and health risk compared to an appropriate reference. 
Recently a third class of monitoring activities was proposed: 
biological effect monitoring (BEH) (zielhuis & Henderson, 1966). 
The continuing development of methods to detect primary effects 
of mutagenic or carcinogenic agents in humans necessitates this 
new class of monitoring activities. BEH is the measurement and 
assessment of early biological effects, irrespective of their 
significance to health, in exposed workers to evaluate exposure 
and health risk to an appropriate reference. 
1.4.1 Environmental Monitoring 
Environmental monitoring is the measurement and assessment of 
agents at the workplace to evaluate ambient exposure and health 
risk compared to an appropriate reference. In workplaces the 
environmental monitoring consists mainly of air measurements. 
This may be personal monitoring or static area monitoring at a 
fixed position. The most widely used method for air pollutants 
containing PAH is the measurement of the benzene or cyclohexane 
soluble fraction of suspended particulate matter (coal tar pitch 
volatiles, NIOSH method PCAM 217, NIOSH 1977). it is a simple, 
non-laborious method. This method is valid on the assumption 
that the fraction of carcinogenic compounds is constant. 
However, other non-PAH containing sources of soluble 
particulates may bias the results. 
A second method is the determination of a single PAH in airborne 
particulate matter as a representative marker of exposure to 
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PAH. Repeated measurements within a certain workplace show a 
relatively constant PAH-profile (Blome, 1981). However, Blome 
(1981) showed that PAH profiles in airborne particulates of 
different workplaces are not constant (Table l.VII). Therefore 
this way of measurement is properly used when one compares 
measurement results of workplaces with a similar PAH-source, but 
measurements of PAH in workplaces with fundamentally different 
PAH-sources cannot be compared. 
TABLE l.VII Occurrence of 8 PAH' in б work environments 
(expressed as percentage of the total PAH). The 
PAH-profile was determined in particulate matter' 
coke oven 
impregnation 
of bricks 
with hot tar 
Al-industry 
handling of 
hot pitch 
foundry 
rolling-mill 
a 
25 
30 
15 
40 
33 
7 
Ь 
17 
22 
11 
35 
22 
9 
с 
8 
16 
10 
9 
θ 
2 
d' 
11 
15 
β 
б 
9 
2 
e
3 
5 
3 
7 
2 
5 
2 
f»+ g' 
16 
11 
23 
4 
10 
9 
h 
5 
1 
7 
1 
3 
3 
1
 Adapted from Blome H, 1981 
1
 carcinogenic to animals 
' a - fluoranthene e - benzolalpyrene 
b - pyrene f - benzofbjfluoranthene 
с - chrysene g - benzofkjfluoranthene 
d - benz[a]anthracene h - benzo[ghiJperylene 
A third method is the measurement of a group of PAH (for example 
the 6 Borneff components (Borneff & Kunte, 1969) or the 16 
EPA-components (EPA, 1979)) or a complete analysis. This type 
of measurement is more informative, but laborious. For routine 
control a complete analysis is out of the question. Bjarseth et 
al (1978a, b) published very detailed investigations on PAH in 
the work environment, they showed that PAH with 2 or 3 aromatic 
rings are present as gaseous pollutants, whereas the major part 
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of PAH with 4 or more rings is present in the particulate 
matter. 
A basically different method is the measurement of the 
biological activity of suspended particulates. Short-term 
mutagenicity tests were used to monitor the presence of mutagens 
in air filter samples. Monarca et al (1982) measured airborne 
mutagens in a petroleum pitch and coke plant with the 
Salmonella/microsome assay and Krokje et al. (19Θ5) tested filter 
samples in the work atmosphere of an aluminium plant for the 
presence of mutagens. Bos et al (19Θ4) tested contaminated 
surfaces of a creosote impregnating plant for mutagens with a 
wipe-test. Kcakje et al (1985) tested the expectorates of 
workers in an aluminium raffinage plant for mutagens. The 
latter method approximates the target dose for the respiratory 
tract. As yet, the occurrence of mutagens in the work 
environment cannot be evaluated quantitatively, because of the 
absence of dose-response relationships. So far, additional 
measurements for the presence of mutagens will be valuable in 
assessing exposure. Research on this topic is necessary before 
it can be used as a routine tool in occupational hygiene. 
1.4.2 Biological Monitoring 
Biological monitoring is primarily an activity where repetitive 
measurements of toxic chemicals in biological specimens is used 
to assess the exposure levels of individual workers and of 
groups of workers. Up to now 3 ways of biological monitoring of 
PAH have been proposed: (a) the urinary mutagenicity assay, (b) 
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reduction of urinary PAH-metabolites to their parent compounds 
and (c) determination of the unmetabolized b(a)p in body fluids. 
The urinary mutagenicity assay has been applied for the 
detection of exposure to PAH. Volunteers and dermatological 
patients excreted mutagenic urine after application of crude 
coal tar to the skin. (Wheeler et al, 1981; Clonfero et al, 
1986). Several groups reported the application of this assay 
for assessing occupational exposure to PAH. Four investigating 
groups failed to detect an enhanced excretion of mutagens in 
urine of workers exposed to PAH (Clonfero et al, 1984; Haller & 
Dybing, 1980; Recio et al, 1984; Bos et al, 1984). However, 
Kriebel et al (1983) reported a higher mutagenic activity in 
urine of coke plant workers than in non-smoking referents. 
Among non-smoking employees of an aluminium plant a slight but 
significantly higher percentage of exposed workers had a higher 
urinary mutagenicity than non-exposed workers (Heussner et al, 
1985). 
An interesting monitoring method was presented by Becher & 
BJBrseth (1983). They proposed the chemical reduction of 
oxidation products of PAH in urine to the parent compounds to 
monitor PAH exposure. The ultra low level of PAH in urine of 
exposed workers, as measured with this method is explained in 
terms of low activity of PAH in humans (Becher et £І, 1984; 
Venier et al, 1985; Haugen et al, 1986). However, this method 
was not validated with positive animal urine samples or spiked 
human urine samples (Becher, 1985). As yet, the results are 
inconclusive. 
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с. Other reports deal with the measurement of unmetabolized b(a)p 
as an indicator of PAH. Hutcheon et al (1983), using a 
radio-immunoassay (RIA), found a higher level of b(a)p in plasma 
of occupants of an urban-industrial area compared to an outer 
suburban area (1.62 vs. 0.04 μ<}/1). Szyja (1977) showed that 
blood and urine samples of 76 highly exposed coke-oven workers 
contained b(a)p (GM- 17.5 /ig/1 and 4.7 //g/1 respectively). Song 
et al (1983) reported a method for the determination of b(a)p in 
urine. Urinary b(a)p levels in operators working on the top of 
the coke oven were higher than those in operators working at the 
side of the coke-oven (AM-0.063 and 0.026 //g/l respectively). 
B(a)p was not found in urine samples of non-exposed workers 
(< 0.010 j/g/l) (Song, 1984). Michels & Einbrodt (1979) found 
significant differences of b(a)p and benz(a)anthracene (b(a)a) 
between urine samples collected in polluted areas and samples 
from a scarcely polluted area of reference; (b(a)p : 0.53 vs. 
0.40 ug/1 and b(a)a : 0.55 vs. 0.42 ug/1). The presence of 
b(a)p in the body as reported by Hutcheon, Song, Szyja and 
Hichels & Einbrodt may be overestimated by interferences of 
hydroxylated metabolites, due either to the known 
cross-reactivity of the RIA for 3-OH-b(a)p (Kado, 1978) or to 
separation techniques with poor discrimination. 
A HPLC method for measuring b(a)p and phenolic b(a)p-
metabolites in urine is proposed by Mathieu et al, 1985. They 
did not report measurements in urine samples from exposed 
individuals. 
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1.4.3 Biological Effect Monitoring 
The prevalence of four different biological effects in 
PAH-exposed workers were reported as a method of monitoring, 
namely (a) the determination of b(a)p-DNA-adducts in peripheral 
blood lymphocytes, (b) sister chromatid exchanges in blood 
lymphocytes, (c) chromosomal aberrations in cultured lymphocytes 
from blood samples and (d) semen abnormalities. 
a. Metabolic pathways of PAH-DNA-adducts have been identified in 
cultured human tissues and cells experimentally exposed to 
radio-labeled PAH (Cohen et al, 1979; Harris et al, 1982; Grover 
et al, 1976). The carcinogenic potency of various PAH shows a 
fairly good correlation with their ability to form adducts with 
DNA (Brookes & Lawley, 1964; Miller 1978; Pelkonen et al, 1980). 
The recent development of highly sensitive immunoassays such as 
ELISA (Perera et al, 1982), and USERIA (Harris et al, 1985) and 
synchronous fluorescence spectrometry (Vahakangas et al, 1985, 
1986) has made that the determination of b(a)p-DNA adducts in 
peripheral white blood cells or blood antibodies of adducts of 
exposed individuals is possible. The determination of adducts 
has been suggested as a dosimeter of the biological effective 
dose. 4 out of 5 patients hospitalized for lung cancer appeared 
to have low, but measurable levels in lung-DNA. 2 of the 4 
lung-adduct positive patients were positive when testing 
peripheral blood mononuclear cell DNA for b(a)p-adducts, but 
also one of the negative patients had b(a)p-DNA-adduct in blood 
(Perera et al^ , 1982). IB of 27 smoking and non-smoking coke 
oven workers had detectable levels of b(a)p-DNA-adducts in the 
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peripheral blood lymphocytes. These adducts were not detectable 
in blood from 9 laboratory workers (Harris, 1985). Shamsuddin 
et al (1985) found 7 from 38 roofers and 7 from 20 foundry 
workers positive for b(a )p-DNA-adducts. There was a marked 
interindividual variation in the levels of adduct (50-fold). 
About one-third of 38 workers in a coke oven plant showed 
b(a)p-DNA adducts in lymphocytes using USERIA. 4 of them showed 
adducts using fluorescence spectrometry. Antibodies to 
b(a)p-DNA were found in one third of the workers (Haugen et al, 
1986). However, smoking referents were also positive (n-2). 
The 7 non-smoking referents were negative. Up to now, the 
measuring data are insufficient and reports are inconclusive to 
be able to evaluate this interesting blood DNA-adduct monitoring 
method. Exposed individuals do show detectable b(a)p-adducts, 
but the specificity of the method for b(a)p-exposure is still 
unclear. 
b. Mice exposed to b(a)p showed a dose-dependent increase of 
SCE-frequency of peripheral lymphocytes (Klingerman et al, 
1985). Coke oven workers showed a slight, but not significant 
increase of SCE-frequency compared to matched steel plant 
workers (n-12) (Miner et al, 1983). Workers of an aluminium 
plant exposed to a similar level did not reveal an increase of 
SCE-frequency compared to a non-exposed control group (n=15) 
(Becher et al, 1984). 
c. The frequency of chromosomal aberrations in the peripheral 
lymphocytes of 22 smoking and non-smoking coal tar workers was 
increased compared to an age and social habits matched control 
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group (Srám et al, 1983). Overall chromosomal aberration rates 
in cultured lymphocytes from blood samples of workers in an 
aluminium reduction plant were similar in both the exposed and 
the non-exposed workers (n=50) (Heussner et al, 19Θ5). 
d. In the latter study semen was also examined. The semen samples 
were used to measure sperm count, percent abnormal sperm 
morphology and frequency of sperm carrying double fluorescent 
bodies. The results of semen analysis failed to detect 
differences between exposed and non-exposed workers (Heussner et 
al, 19Θ5). 
1.5 BACKGROUND AND OBJECTIVE OF THE THESIS 
1.5.1 Development Of A Method For Biological Monitoring Of PAH 
Two reasons are given for the development of a biological 
indicator of exposure. 
1.5.1.1 Health Effect Related - The greatest advantage of 
biological monitoring is that the biological parameter is more 
directly related to the internal dose. Therefore it may offer a 
better parameter in the estimation of health risk than 
environmental monitoring (figure 1.1). 
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Figure 1.1 Relationship between environmental exposure, internal 
exposure and effects 
1.5.1.2 Route Integrated Exposure - Biological monitoring takes 
into consideration absorption by other routes than the lungs. 
It has been demonstrated that PAH can also enter the body by 
absorption through the skin (Cernikova et al., 1963; Wheeler et 
al, 1981; Storer et al_, 19Θ4) and through the intestinal tract 
(Chang, 1943; Yamazaki et al, 19Θ2). Skin exposure may be 
considerable for coal tar and pitch workers, because these types 
of work environment are often highly contaminated and the 
workers wear few clothes, as the heat stress in such work 
environments is often great. 
1.5.2 Conditions For The Development Of A Method Of Biological 
monitoring. 
1.5.2.1 Knowledge Of Toxicokinetics Of PAH. - The knowledge of 
the metabolism of benzola((pyrene, one of the PAH, is extensive. 
In many studies on chemical carcinogenesis, b(a)p has been used 
as a model substrate. Excellent metabolism reviews have been 
presented (Dipple, 19Θ3; Phillips, 19Θ3). The intermediary 
- 19 -
epoxide-PAH and dihydrodiol-epoxide-PAH are supposed to be 
crucial metabolites in the carcinogenesis of PAH. The 
interindividual variation of the metabolism of PAH in cultured 
human tissues and cells is great (Harris et ill, 1982). The 
excretion of PAH-metabolites has been studied in experimental 
animals. After inhalation of b(a)p by rats most of the excreted 
metabolites (85-95%) were found in the faeces (Mitchell, 1983; 
Sun et al, 1982). A minor part was excreted in urine. 
1.5.2.2 Knowledge Of The Toxicodynamics Of PAH - Intermediary 
dihydrodiol-epoxide-PAH with a "bay-region" were recognized to 
be important in the process of DNA-adduct formation (Pelkonen & 
Nebert, 1982; Conney, 1982). However, "non bay-region" 
dihydrodiol-epoxides also have the same properties (Sims and 
Grover, 1981). Host of the research on the toxico-dynamics has 
been performed in in vitro systems. Metabolic pathways and 
repair mechanisms might differ from the in vivo situation. 
The formation of DNA-adducts at the cell level is supposed to be 
the first initiating step in the process of cancer development. 
Knowledge of the relationship of DNA-adduct formation and the 
development of maligne or benigne tumors is limited. The 
epidemiology of PAH exposed workers shows excess rates of cancer 
in tissues of epithelial origin (see paragraph 1.2). 
1.5.2.3 Validation Of A Biological Test - When the basic 
toxicological investigations have suggested a useful biological 
parameter, other demands muet be met before applying this test 
in preventive industrial health care. 
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The demands of a valid biological parameter (Lauwerys, 1982) are 
- sufficiently sensitive 
(low detection limit, high accuracy and high reproducability) 
- sufficiently specific 
(little interfering factors) 
- sufficiently stable to allow storage of samples 
- non-time consuming analysis by a not overly sophisticated 
technique 
- when these demands are met a normal value among non-exposed 
referents must be determined. 
1.6 OUR INVESTIGATIONS 
The family of PAH is large. As many as 45 different PAH have 
been detected in the work environment (Bjorseth & Eklund, 1979). 
The known carcinogenic PAH are among the PAH with 4 or more 
rings. From this group we selected two 'markers', 
benzo(a)pyrene and pyrene. 
The human metabolism of b(a)p and pyrene was investigated in 
vitro. The major hydroxylated metabolites of b(a)p and pyrene 
were recognized after the incubation of isolated PAH and coal 
tar in human liver preparations. The correlation between the 
development of mutagenic metabolites and a marker metabolite 
(1-hydroxypyrene) was studied after bioactivation of coal tar in 
liver preparations from several kidney transplant donors. The 
results of these studies are presented in CHAPTER 2 and 3. 
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For practical reasons the excretion of metabolites was chosen as 
the exposure parameter to be investigated. Urine was taken as 
the biological specimen. There was little interference from 
other urinary constituents in the region of the hydroxylated 
b(a)p and pyrene after separation by reversed phase high 
performance liquid chromatography (HPLC). These chromatographic 
properties together with the high fluorescence of 
hydroxylated-PAH and the enzymic hydrolysis of conjugated 
metabolites gave the basis for the development of a very 
sensitive assay. The assay is described in CHAPTER 4. 
The toxicokinetics and excretion of b(a)p and pyrene were 
studied in experimental animals after oral ingestion and 
percutaneous penetration. The results are described in CHAPTERS 
5, 6, 7 and 8. 
The identification of metabolites in human urine is presented in 
the CHAPTERS 7 and Θ. In these chapters several tests to assess 
PAH exposure, viz. urinary mutagenicity, urinary 
3-hydroxybenzo(a)pyrene and urinary 1-hydroxypyrene are 
compared. The results of field studies of exposed patients, 
several groups of workers exposed to PAH and non-exposed 
referents are presented in the CHAPTERS 7, 8 and 9. 
Finally, CHAPTER 10 discusses in general the suitability and 
applicability of the suggested method in occupational hygiene. 
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CHAPTER 2 
INTERINDIVIDUAL DIFFERENCES IN HYDROXYLATION OF 
BENZO[a]PYRENE AND PYRENE IN HUMAN LIVER PREPARATIONS 
FRANS J. JONGENEELEN, FERD HERMANS, ROB B.M. ANZION, 
HENNY H.J. ROELOFS and PETER Th. HENDERSON. 
Submitted for publication. 
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ABSTRACT 
The 9000 χ g supernatant (S9) of liver samples from fifteen 
kidney transplant donors was used to study the variation of the 
human metabolism of polycylic aromatic hydrocarbons in vitro. 
The differences between the S9-preparations were studied with 
benzo[a]pyrene and pyrene using high pressure liquid 
chromatographic separation of metabolites. In this in vitro 
system, 1-hydroxypyrene was the major metabolite of pyrene, and 
3-hydroxybenzo[a]pyrene was the major metabolite of 
benzo[ajpyrene. The parameters of the isoenzyme kinetics 
(Michaelis-Menten constant - apparent Km and maximum reaction 
velocity - Vmax) of the 15 donors were estimated for the 
hydroxylation of pyrene to 1-hydroxypyrene and the hydroxylation 
of benzo[a]pyrene to 3-hydroxybenzo[a]pyrene. The average 
apparent affinity of the isoenzymes for benzo(a]pyrene 
hydroxylation was of the same magnitude as the average affinity 
for pyrene hydroxylation. The average Vmax of the liver 
preparations to pyrene, however, was 10-fold higher than that of 
benzo[a¡pyrene. Large differences of the apparent isoenzyme 
constants were found (350-fold). The differences of metabolic 
clearance were small. The data show a significant correlation 
between the Vmax of benzolajpyene and the Vmax of pyrene 
hydroxylation in the human liver preparations. 
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INTRODUCTION 
There are large differences among different individuals in their 
capacity to metabolize environmental carcinogens such as 
polycyclic aromatic hydrocarbons (PAH)* (1-4). PAH are 
converted by several enzyme systems either into reactive 
electrophiles, which may attack cellular targets like DNA, or 
into detoxified products. Both pyrene and BP are present as 
major components of the total content of PAH in the environment. 
The available data provide no evidence that pyrene is 
carcinogenic and sufficient evidence that BP is carcinogenic to 
experimental animals (5). Several cytochrome P-450 
mono-oxygenase enzyme systems catalyse the formation of reactive 
arene oxides. Cytochromes P-450 are present in different 
molecular forms in each animal species. Up to eight differently 
distributed forms of cytochrome P-450 (isoenzymes) were found in 
human liver microsomes (1). 
Both 1-OH-pyrene and 3-OH-BP are metabolites which are 
partly excreted by man and rat and partly undergo further 
metabolism (6,7). The determination of 1-0H- and 
3-OH-derivatives in urine of exposed humans has been suggested 
for the assessment of exposure to PAH (7). The present paper 
describes the individual differences of kinetic parameters 
(Hichaelis-Menten constant « Km and maximum reaction velocity -
Vmax) for the hydroxylation of pyrene and BP in liver 
preparations (S9-mix) of 15 individuals. 
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* abbreviations: 
PAH, polycyclic aromatic hydrocarbons; 
АНН, aryl hydrocarbon hydroxylase; 
BP, benzo[aJpyrene; 
DHSO, dimethylsulphoxide; 
3-OH-BP, 3-hydroxybenzo t a)pyrene ; 
9-OH-BP, 9-hydroxybenzo[a]pyrene ; 
BP-7,8-diol, trans-7,8-dihydro-7,8-dihydroxybenzo[a]pyrene; 
BP-9,10-diol, trans-9,10-dihydro-9,10-dihydroxybenzo[a Jpyrene; 
BP-4,5-diol, trans-4,5-dihydro-4,5-dihydroxybenzo[a]pyrene; 
1-OH-P, 1-hydroxypyrene; 
NADP, nicotinamide adenine dinucleotide phosphate; 
Km, Michaelis-Menten constant; 
Vmax, maximum initial reaction velocity; 
HPLC, high pressure liquid chromatography. 
MATERIALS AND METHODS 
Chemicals 
The two test compounds were dissolved in DMSO (p.a. Merck, 
Darmstadt, FRG). Analytical grade pyrene (purity > 99%) was 
obtained from Serva (Heidelberg,. FGR). 1-OH-P and BP (p.a.) 
were obtained from Janssen Chimica (Beerse, Belgium). BP 
metabolite reference standards were obtained from the Chemical 
Carcinogen Standard Reference Repository (IITRI, Chicago, USA). 
NADP-disodium salt and glucose-6-phosphate-disodium salt were 
from Sigma (St. Louis, USA). All other chemicals were of the 
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highest purity obtainable. 
Preparation of liver 9000 χ g supernatant 
Postmortal human liver tissues were obtained from kidney 
transplant donors. All of them died because of traffic 
accidents. The sex and age of the donors are given in table 
2.1. After the removal from the body, the liver sample was 
perfused with and placed in ice-cold saline. The liver sample 
was kept on ice until the preparation of the hepatic supernatant 
was started. The delay between death and the preparation of the 
liver was less than ten hours with an average of six hours. The 
preparation of the post mitochondrial fracton (9000 χ g 
supernatant - S9) of human livers was performed according to the 
method for rat liver 9000 χ g (8) with an extra pre-treatment 
(9). The supernatant was frozen in liquid nitrogen and stored 
at -вСС. von Bahr (10) showed that storage at this temperature 
does not alter the monooxygenase activity in human microsomes. 
Hydroxylation assay 
The enzyme mixture used for the hydroxylation assay (S9-mix) 
contained 0.1 ml 9000 χ g hepatic supernatant per ml and the 
components of standard S9-mix including NADP (4 mM) and 
glucose-6-phosphate (5 mM) according to Maron and Ames (6). The 
hydroxylating activity of these liver preparations was measured 
by incubation 1.96 ml of the S9-mix with 40 μΐ of a solution of 
BP or pyrene in DHSO in closed vials with an inner diameter of 
30 mm. The incubation vials were placed in rotary shaking 
waterbath at 370C for 30 min. The final concentrations of the 
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two substrates were 1.25, 1.65, 2.5 and 5 μη. The incubation 
was stopped by cooling on ice and the 2 ml mixtures were 
immediately extracted twice with 5 ml of ice-cold diethyl ether. 
The organic layers were collected and evaporated to dryness at 
З С С under a gentle flow of nitrogen. The residue was dissolved 
in 2.0 ml methanol. Aliquots were analysed with HPLC. 
Reversed phase HPLC analysis 
The analyses were conducted on a HPLC gradient system (Kipp 
Analytical. The automatic sample injector filled a 20 //1 sample 
loop and injected it subsequently on a 150 * 4.6 mm ID 
Lichrosorb RP 18 (5 μια) column (column temperature was 40oC, 
flow 0.8 ml/min). The solvent gradient for the ether soluble 
BP-metabolites started with 5 min 90% solvent A (60% water, 40% 
methanol) followed by a linear gradient to 90% solvent В (100% 
methanol) in 35 min. This was hold for 10 min. The ether 
soluble pyrene metabolites were analysed with a faster gradient: 
10 to 90% solvent В in 15 min. The 90% solvent В was hold for 5 
min. These HPLC analyses allowed the base line separation of 
PAH metabolites. The Chromatograph was equiped with a 
programmable fluorescence spectrophotometer (Perkin Elmer, type 
LS4) which had the ability to change the pair of wavelenghts 
during the run. Excitation and emission slits were set on 10 
and 20 nm, respectively. The following fluorescence wavelenghts 
were used: 
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period of run lambda ex lambda em 
pyrene incubation whole run 242 386 
BP incubation 0-24 min 280 406 
24-32 min 273 410 
32-57 min 265 430 
Under these conditions, the dihydrodiol- and the 
hydroxy-derivatives of BP could be measured with maximum 
sensivity. 
Statistical methods 
Data analysis was performed with the SAS computer software. 
Correlation was qualified with Spearman's rank correlation 
coefficients (r
s
). The probability under the null hypothesis 
H : ρ-0 is calculated. The level of significance was 0.05. 
RESULTS 
Figure 2.1 shows a representative HPLC-profile of the ether 
soluble metabolites from the incubate of pyrene with the human 
hepatic preparations (S9-mix). Under the given conditions, all 
chromatograms showed only one metabolite : 1-OH-P (figure 2.1). 
Figure 2.2 shows the HPLC-profile of the ether soluble 
metabolites from the incubate of BP with human hepatic enzyme 
mixtures. The HPLC analyses of the BP incubation revealed 
various metabolites: 3-OH-BP in major quantities and 
9,10-diol-, 4,5-diol-, 7,8-diol- and 9-OH-BP in minor quantities 
(figure 2.2). The kinetic constants for the sum of the 
cytochrome P-450 mono-oxygenases and competing reactions of each 
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liver samples were estimated on the basis of the formation of 
the hydroxylated metabolites, namely 1-OH-P and 3-OH-BP. 
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Fig. 2.1. HPLC-chromatogram of the ether soluble metabolites of 
pyrene in a human liver preparation (a) and a 
chromatogram of the 1-hydroxypyrene reference (b). 
Excitation/emission wavelength - 242/38Θ nm. 
I - 1-hydroxypyrene, II » pyrene. 
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Fig. 2.2. HPLC-chromatogram of the ether soluble metabolites of 
benzot a)pyrene in a human liver preparation (a) and a 
chromatogram of the benzol a)pyrene metabolite 
references (b). The three pairs of fluorescence 
excitation/emission wavelengths were set in the 
course of the run and are indicated. 
I - 9,10-dihydrodiol-benzo(a)pyrene 
II « 4,5-dihydrodiol-benzo(a)pyrene 
III - 7,8-dihydrodiol-benzo(a)pyrene 
IV - 9-hydroxybenzo(a)pyrene. 
V - 3-hydroxybenzo(a)pyrene 
VI - benzo(a)pyrene 
During the three months of experimental work, one 
experiment was repeated 24 times under identical conditions. 
This experiment, the incubation of 50 μΗ pyrene with S9-mix of 
donor n* 1, gave the data to calculate the total of biological 
and analytical variability of the hydroxylation assay. The 
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relative standard deviation of this in vitro test was 19% 
(n-24). 
metabolite production IJJM) 
¿0 60 
incubation time (mm) 
rig. 2.3. Reaction rate of the hydroxylation of pyrene and 
benzo[a]pyrene in human hepatic 9000 χ g supernatant 
(donor n^ 1). The initial concentration was 50 μΗ. 
The reaction rate as a function of incubation time was 
studied with the liver preparation from donor n^ 1. Pyrene 
(50 μΗ) and BP (50 //M) were each incubated for different time 
periods between 0 and 60 min. Figure 2.3 shows the production 
of the hydroxylated metabolites in the time, it is obvious that 
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the reaction velocity of pyrene hydroxylation was constant for 
at least the first 60 min and that the reaction velocity of BP 
hydroxylation was constant for the first 50 min of incubation. 
The 30 min incubation time of the substrate was the optimum 
between linearity of the reaction curve and maximized metabolite 
production. Figure 2.3 also shows that the hydroxylation 
pathway of pyrene is more important than that of BP. 
The kinetic constants of the isoenzymes involved in the 
hydroxylation of pyrene and BP were determined after the 
separate incubation of each substrate for 30 min at four 
different concentrations. A double reciprokal plot of the in 
vitro hydroxylation rate against the substrate concentration 
(Lineweaver-Burk plot) was made for each liver preparation to 
estimate the characteristic variables (apparent Km and Vmax) of 
the isoenzymes responsible for the hydroxylation of both 
substrates. The apparent Km and Vmax-values were calculated 
using linear regression analysis. Table 2.1 shows the results. 
The average Km-value of the isoenzymes for both PAH was of the 
same magnitude. However, the average Vmax of the hydroxylation 
of pyrene was approximately ten times higher than that of the BP 
hydroxylation. 
Large interindividual differences in the 15 liver 
preparations of both the apparent substrate affinity and the 
maximum reaction velocity were seen. The liver preparations of 
the donors no 2, 3 and 9 seemed to be divergent from the other 
12 preparations; the Vmax of the BP and pyrene hydroxylation 
reactions of these three preparations were very low and the 
- 41 -
apparent affinities for pyrene hydroxylation were very high. 
Because of a limited amount of some liver samples, some data are 
missing in table 2.1. 
TABLE 2.1. Data of donors and parameters of cytochrome P-450 
isoenzyme kinetics of human hepatic 9000 χ g 
supernatant towards pyrene and benzol a]pyrene, 
respectively. 
№ 
1 
2 
3 
4 
5 
6 
7 
β 
9 
10 
11 
12 
13 
14 
15 
sex 
F 
F 
M 
H 
И 
M 
M 
M 
и 
H 
η 
M 
и 
F 
M 
age 
16 
19 
35 
35 
22 
20 
22 
51 
47 
20 
4 
46 
15 
18 
20 
Geometric mean 
1-hydr 
Km1 
27.4 
0.67 
0.43 
8.1 
. 
5.2 
# 170 
0.62 
2.65 
13.20 
9.26 
2.06 
. 
2.54 
4.44 
oxypyrene 
Vmax2 
0.73 
0.03 
0.03 
0.24 
. э 
0.26 
. 
4.5 
0.03 
0.09 
0.36 
0.25 
0.16 
. 
0.13 
0.18 
3-hydroxy-
benzo[a]py 
Kmu 
1.70 
2.83 
1.28 
2.37 
1.18 
. 
0.76 
3.65 
1.19 
. 
2.56 
5.80 
1.62 
122.20 
1.15 
2.55 
rene 
Vmax2 
0.015 
0.003 
0.002 
0.018 
0.020 
, 
0.007 
0.023 
0.002 
. 
0.013 
0.022 
0.010 
0.710 
0.006 
0.012 
4 μΠ 
2) nmol/hr/mg wet liver 
') not determined 
The parameters of the isoenzymes kinetics of the 15 liver 
preparations were studied for correlation. A correlation matrix 
showing the coefficients is given in table 2.II. The 
correlation between apparent Km and Vmax both for pyrene and BP 
was very high. The Vmax for the pyrene hydroxylation was found 
to correlate significantly with the Vmax for BP hydroxylation. 
The correlation between the apparent affinity of the isoenzyme 
for pyrene hydroxylation and the one for BP hydroxylation was 
42 -
just over the significance level. 
Table 2.II Spearman's coefficients of correlation of the 
constants of isoenzyme kinetics for hydroxylation 
of pyrene and benzol aIpyrene in human hepatic 
9000 χ g supernatant from n* donors 
isoenzyme 
constant 1 2 3 
1. Km (1-OH-P) 
2. Vmax (1-OH-P) 0.92*** 
(12) 
3. Km (3-OH-BP) 0.56* 
(10) 
4. Vmax (3-OH-BP) 0.89*** 
(10) 
*** p< 0.01 
** p< 0.05 
* 0.05< p< 0.10 
* number of donors is given in parentheses. 
DISCUSSION 
Pyrene and BP are initially metabolized by the microsomal 
monooxygenase system to several arene oxides. Several competing 
processes determine the continuation of the metabolism of these 
PAH. Once formed, these arene oxides may rearrange 
spontaneously to phenols, undergo hydration to the corresponding 
dihydrodiols catalysed by epoxide hydrolase or react covalently 
with glutathione. Since there is no known activity to hydrate 
the intermediary 1,2-epoxidepyrene and 2,3-epoxide-BP to the 
corresponding dihydrodiols and a very low glutathione 
conjugating activity in the 9000 χ g liver supernatant, the 
kinetics of the microsomal multienzyme complexes in S9-mix may 
be characterized by the formation of 1-OH-P and 3-OH-BP, using 
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0.48 
(10) 
0.86*** 0.60** 
(10) (13) 
pyrene and BP as substrate, respectively. The HPLC-profile of 
the incubation of BP with human S9-mix is similar to the 
profiles found by other research groups under equal conditions 
(4,11). All these reports show that 3-OH-BP is a major 
metabolite of BP in this system. 
Souhaili el Amri (12) reported about the apparent Km and 
Vmax constants of BP hydroxylase in human liver microsomes using 
the fluorometric assay (13). The apparent Km was close to the 
values of this report. The mean Vmax was a factor 7 lower than 
the reported Vmax. However, the comparison is limited as 
another liver fraction and another hydroxylation assay was used. 
If the substrate concentration is low with respect to the 
Km-value of the enzyme substrate complex, the metabolic 
clearance is a constant. In these conditions the metabolic 
clearance is considered to be a simple function of the enzyme 
constants governing the biotransformation (metabolic 
clearance » Vmax/Km) (14). The highly significant correlation 
between apparent Km and Vmax both for the pyrene and for the BP 
hydroxylation was rather surprising. It means that the 
differences in metabolic clearance are rather small; a low 
apparent affinity is associated with a high Vmax and a high 
apparent affinity is associated with a low Vmax. 
The intra- and inter-tissue differences of the BP 
metabolism within the same individual are generally within one 
order of magnitude. The interindividual differences of 
monooxygenase activity in cultured human tissues and cells, 
however, are wide (5 to 300-fold), just as the binding of the 
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activated BP to DNA (50 to 150-fold) (15). This report showed 
great differences in the constants of cytochrome P-450 
isoenzymes of the S9 liver preparations (Km: 350-fold, 
Vmax: 350-fold). The variation of the Km might be under 
different genetic control and/or might be a result of different 
environmental exposure to P-450 inducers prior to death. A test 
for the polymorphic distribution of the enzyme constants would 
be interesting, however, the number of donors was too small to 
test this. It can not de excluded that the differences in Vmax 
were influenced by variations in the preparation of liver 
homogenate. 
A high correlation between the formation of phenolic 
BP-metabolites and the precarcinogen 7,8-diol-BP was found using 
human placental microsomes from 13 smoking women (16). However, 
no correlation seems to exist between the DNA-binding level and 
the total metabolism in tissues from different species (17,18). 
Whether the individual variation of 3-OH-BP in human tissues 
correlates with the individual variation of the formation of 
BP-DNA adducts is not known yet. 
The experimental results showed that 1-OH-P was a major 
metabolite of this human in vitro metabolism of pyrene; no 
other metabolites were detected after incubation in the human 
liver preparations. 1-OH-P and 3-OH-BP have been identified in 
urine of persons exposed to PAH (7); the first metabolite in 
major and the latter in minor quantities. This report shows 
that the in vitro hydroxylation of pyrene can be a good 
estimator for the in vitro hydroxylation of BP. Since 
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environmental exposure to PAH always occurs in mixtures of many 
PAH, a practical consequence of this finding is that is supports 
the suggestion that urinary 1-OH-P can be used as a marker to 
assess exposure to PAH (7). 
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CHAPTER 3 
MUTAGENICITY OF CRUDE COAL TAR AFTER ACTIVATION WITH HUMAN 
LIVER PREPARATIONS; FORMATION OF 1-HYDROXYPYRENE AS AN 
INDICATOR OF THE MUTAGENIC ACTIVATION CAPACITY. 
FJ JONGENEELEN, W vd AKKER, RP BOS, RBM ANZION, JLG THEUWS, 
HMJ ROELOFS and PTh HENDERSON. 
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ABSTRACT 
Liver S9 fractions were prepared from male Wistar rats, either 
non-induced or induced with aroclor 1254 and from five human 
kidney transplant donors. The preparations were compared for 
their ability to metabolize the pre-mutagens present in crude 
coal tar and benzo(a)pyrene to mutagenic metabolites in the 
Salmonella mutagenicity assay towards strain ΤΑ9Θ. Low levels 
of mutagenicity of crude coal tar and benzo(a)pyrene were 
observed with human S9 preparations. The differences between 
the S9-mix of the five donors in capacity to activate 
premutagens were approximately 6-fold. The activation of crude 
coal tar by rat liver S9 preparations was higher than by the 
human S9 preparations. The metabolic conversion of pyrene in 
coal tar to 1-hydroxypyrene was determined in a parallel assay 
of microsomal enzyme activity. Three human preparations showed 
a high correlation between the formation of 1-hydroxypyrene and 
mutagenic metabolites. The slope values of the individual 
regression lines were equal, suggesting that the 1-hydroxypyrene 
is a good indicator for the activation of pre-mutagens present 
in crude coal tar. 
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INTRODUCTION 
Crude coal tar, a by-product of coking operations has remained a 
poorly characterized mixture of chemicals. Crude tar samples 
derived from coals of different geographical origin were found 
to be similar in their major constituents. The list of 
potential carcinogens in coal liquids alone is quite impressive 
and includes a variety of PAC's : the polycyclic aromatic 
hydrocarbons (PAH), sulfur containing PAC, oxygen containing PAC 
and nitrogen containing PAC. The PAH and amino-PAH are 
recognized to be potent mutagens in coal liquids (IARC, 1983; 
Wilson 1980) and the mass balance of crude coal tar shows that 
approximately 60 wt % of tar are PAH, whereas the basic fraction 
of crude coal tar (N-PAC and amino-PAH) makes only 2 wt % [Later 
et al, 1991). 
Usually the Salmonella microsome test is performed using 
liver S9 from aroclor treated rats. The mutagenicity of 
compounds after activation by human liver S9 differs 
non-systematically from results obtained with rat liver S9 
[Bartsch et al, 1975,1980; Beaune et al, 1985; Dybing et al 
1979; Hutton & Hackney 1975; Neis et al, 1986; Tang & Friedman, 
1977]. Relatively little work has been done with human liver 
preparations, in spite of the expected improved predicting value 
with respect to the assessment of human genotoxic risks. 
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A high correlation was found between the urinary 
mutagenicity and the urinary 1-hydroxypyrene after application 
of crude coal tar on the dorsal skin of rats [Jongeneelen et al, 
1986]. In the present study, we tested the mutagenicity of 
crude coal tar with rat liver S9 fractions and five human liver 
S9 fractions in the Salmonella assay. In addition, the 
correlation between the mutagenicity of crude coal tar and the 
formation of 1-hydroxypyrene in vitro using the same human 
metabolic activation systems was studied. 
MATERIALS AND METHODS 
Test compounds 
The test compounds were dissolved in dimethylsulphoxide (DMSO, 
p.a. Merck, Darmstadt, FRG). Crude coal tar (crude coal liquid 
from coke works) was obtained from Cindu Chemicals BV (Uithoorn, 
Holland). Benzo(a)pyrene, D-biotin, L-histidine-HCl, 
nicotinamide adenine dinucleotide phosphate (NADP) disodium salt 
and glucose-6-phosphate (G-6-P) disodium salt were from Sigma 
(St. Louis, USA). Purified agar was from Difco Laboratories 
(Detroit, USA) and nutrient broth No 2 from Oxoid Ltd 
(Basingstoke, UK). 1-Hydroxypyrene was obtained from Janssen 
Chimica (Beerse, Belgium) and the PAH references were from the 
Community Bureau of References (BCR, Brussels, Belgium). 
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Preparation of rat and human S9 liver fractions 
Rat liver S9 (9000xg supernatant) fractions were prepared from 
pooled male Wistar rats, either non-treated or pretreated with 
Aroclor 1254, according to Maron & Ames [1983]. The human liver 
samples were from five kidney transplant donors. Age and sex of 
the donors are listed in table 3.1. After the removal of the 
postmortal liver tissue from the body, the perfused liver sample 
was kept on ice until the preparation of liver metabolic systems 
Table 3.1. Total cytochrome P-450 and protein content 
measured in a sonicated suspension of hepatocytes 
from five human donors and Wistar rats '. 
HUNAN DONORS 
№ donor age (years) sex P-4502 protein2 
6 б 
praol/10 cells /ig/10 cells 
51 M 360 
16 F 112 490 
19 F 95 500 
35 И 85 400 
30 F 124 
uninduced 
Aroclor induced 
RATS 
age (weeks) 
11 
11 
sex 
η 
M 
P-450 
270 
protein 
880 
1
 three rats were used in preparing hepatocytes and S9-fraction 
2
 Cytochrome P-450 and protein are expressed per 1,000,000 
hepatocytes 
was started. The delay betwepp death and the preparation of the 
liver was less than ten hours with an average of six hours. The 
effect of the time delay on the metabolic activity of the 
preparations was tested with rat liver. No significant 
differences were found between freshly prepared liver and the 
for 7 hour on ice preserved liver [Roelofs, unpublished 
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1 
2 
3 
4 
5 
results]. Human liver S9 fractions were prepared by the same 
procedure used for rat S9 [Karon & Ames, 19Θ3], after mincing of 
frozen pieces of human liver as described in Neis et al (19Θ6). 
The supernatant was frozen in liquid nitrogen and stored at - 80 
eC. 
Salmonella/miсrosóme plate assay 
The mutagenicity assay was performed according to the method of 
Macon & Ames [1983] with Salmonella typhimurium TA98. The liver 
metabolic system (S9-mix) contained 0.1 ml 9000xg (S9) hepatic 
supernatant per ml, either from rat or man, and the components 
of standard S9-mix including NADP (4mN) and glucose-6-phosphate 
(5mJ1) according to Ma ron & Ames (1983). The test compound was 
dissolved in DMSO. Every determination was done in triplicate. 
The mutagenicity data are reported as the mean number of 
revertant colonies ± SEM. 
Assay of pyrene hydroxylase activity 
The hydroxylating activity of the same human and rat liver 
preparations was measured after incubation of 1.96 ml of the 
liver S9-mix with 40 μΐ of a solution of the crude coal tar in 
DMSO in a rotary shaking bath at 37 °C. A incubation time of 3 
h gave optimal results. The same tar sample as applied in 
mutagenicity testing was used. The reaction was stopped by 
rapidly cooling on ice. The 2 ml mixtures were extracted twice 
with 5 ml diethyl ether. The organic layers were collected and 
evaporated to dryness under a gentle flow of nitrogen. The 
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residue was dissolved in 2.0 ml methanol and HPLC-analysed. 
1-Hydroxypyrene was determined using a solvent gradient on a 
reversed phase column (Lichrosorb RP18, 5//m, column temperature 
40 "C) in a Kipp Analytics HPLC (Kipp & Zn, Delft, Holland) with 
fluorescence detection (lambda ex = 242 nra, lambda em - 388 nm). 
The retention time of 1-hydroxypyrene was 31.5 min. The 
detection limit of 1-hydroxypyrene was 100 pmol per 2 ml 
incubation mixture The total of biological and analytical 
variation of the assay was determined in a 8 times repeated 
experiment with one human preparation : coefficient of 
variation (CV) - 9.0%. The results of the experiments with 
metabolic activation systems were corrected for the 
background-value of 1-hydroxypyrene in coal tar (0.03 wt%). 
Cytochrome P-450 and protein content 
The total cytochrome P-450 content and protein was measured in 
the sonicated suspension of isolated hepatocytes of five donors 
and in the sonicated suspension of the hepatocytes of rats (Neis 
et al, 1986). The suspension of isolated hepatocytes was 
sonicated twice for 20 sec. with an interval of 30 sec in a 100 
W Ultrasonic Disintegrator. During this step the suspension was 
cooled on ice. The cytochrome P-450 method was based on the 
difference in absorbance for the cytochrome P-450 CO-complex 
after reduction with sodium dithionite according to the method 
of Omura and Sato [1964]. The molecular extinction coefficient 
of 91 cm-1.mM-1 was used. Proteins were measured according to 
Gogstad & Krutnes (1982) with bovine serum albumine as standard. 
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Statistical methods 
The linear regression lines were calculated with the least 
squares method. The slope values of the regression lines 
(regression coefficient) are presented. 
RESULTS 
PAH content of the crude coal tar 
The PAH content of selected PAH in the tested coal tar was 
measured using HPLC with fluorescence detection in solutions of 
coal tar in methanol and is reported in table 3.II. The content 
of the PAH is not deviating from other crude coal tar samples 
(Lehmann et al, 1986; lASC, 1965). 
Table 3.II Concentration of selected polycyclic 
aromatic hydrocarbons in 
the crude coal tar using HPLC. 
PAH wt % 
fluorene 1.5 
fluoranthene 2.2 
pyrene 2.0 
benz(a)anthracene 0.7 
benzot a)pyrene 0.6 
methanol insoluble residu 19.0 
Hutagenicity 
Coal tar quantities of 0-70 //g per plate were tested. Table 
3.III shows the number of his+ revertants per plate obtained 
with the liver S9-mix of rat and man. Dose-response curves were 
constructed by plotting the revertant colonies versus added 
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concentration. Regression analysis was performed to find the 
best fit of the individual mutagenicity data. Linear regression 
appeared to be the best fit, both for human and rat S9-mix (r > 
0.95) over the 0-70 jig/plate range. The specific mutagenicity 
of crude coal tar was determined in the linear part of the 
dose-response mutagenicity curve (calculated from the slope 
value of the linear regression line) and is also presented in 
table 3.III. 
Table 3.III. Number of revertant colonies per plate of 
Salmonella typhymurium TA98 as a function of the amount 
of crude coal tar after metabolic activation with human and 
rat liver S9-mix ' and specific mutagenicity values. 
donor rats 
coal tar non- aroclor 
ug/plate 1 2 3 4 5 induced induced 
0 
10 
20 
30 
40 
50 
60 
70 
27+7 
51+5 
79+5 
141+10 
165+7 
264+32 
268+16 
270+23 
24+6 
31+3 
39+5 
61+8 
78+11 
101+2 
129+7 
148+6 
21+11 
24+3 
35+6 
58+10 
83+3 
101+16 
97+10 
105+12 
19+5 
21+1 
31 + 5 
30+11 
50+7 
61+7 
58+9 
60+8 
15+8 
23+6 
32+16 
39+4 
50+9 
68+7 
58+20 
64+8 
21+3 
224+5 
315+9 
460+9 
473+6 
559+3 
551 + 5 
618+25 
16+2 
336+7 
634+8 
844+13 
988+17 
1090+17 
1223+44 
1510+26 
revertant 
colonies 
per //g tar 3.99 1.85 1.40 0.69 0.76 7.81 19.5 
1
 preparation of the liver S9-mix is given under material 
section 
It is obvious that the mean mutagenic response to coal tar after 
bioactivation with human preparations is lower than with the 
preparation of the non-treated rat (table 3.III). However, even 
the less active human S9-preparations (donor 4 and 5) showed a 
3-fold increase of revertant colonies at 70 ug/plate compared to 
the background values. 
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A strong dose-response of revertant colonies was found 
using liver S9 from aroclor 1245 treated rats. Liver S9 from 
non-treated rats showed a less strong response. 
As a positive control benzo(a)pyrene (b(a)p) was parallelly 
tested in the Salmonella/microsome test in two concentrations 
(3.75 and 7.5 /yg/plate) towards strain ΤΑ9Θ. Table 3.IV shows 
the results. The highest mutagenic response was obtained with 
the S9-mix from donor 1 and 2. 
Table 3.IV. Number of revertant colonies per plate of 
strain Salmonella typhymurium ΤΑ9Θ as a function of the 
amount of benzo(a)pyrene with human and rat liver S9 mix >. 
b(a) P 
//g/plate 
0 
3.75 
7.5 
1 
27 
5Θ 
75 
2 
27 
61 
80 
3 
21 
24 
30 
donor 
4 
19 
28 
22 
5 
15 
17 
37 
rats 
non-
induced 
18 
438 
524 
aroclor 
induced 
18 
811 
1115 
1
 preparation of the liver S9-mix is given under material 
section 
l-Hydroxypyrene formation 
The conversion of pyrene in coal tar to l-hydroxypyrene by human 
S9-mix as measured in the hydroxylase assay is shown in table 
3.V. Pyrene hydroxylase activity was observed in the S9-mix of 
the donors 1, 2 and 3. Linear regression analysis of 
1-hydroxypyrene formation and mutagenic response at the varying 
amounts of coal tar showed a constant ratio of the metabolic 
capacity to form mutagens and the capacity to form 
1-hydroxypyrene (see figure 3.1). 
Table S.V. 1-Hydroxypyrene formation1 as a function of 
the amount of crude coal tar after metabolic activation 
with human S9-iiiix2. 
/yg coal tar per 
2 ml liver 
preparation 
0 
10 
20 
30 
40 
50 
60 
70 
1 
<100 
297 
672 
953 
1193 
1372 
1600 
1903 
2 
<100 
281 
375 
503 
590 
896 
917 
983 
donor 
3 
<100 
169 
299 
449 
499 
594 
604 
700 
4 
<100 
<100 
<100 
<100 
<100 
<100 
<100 
<100 
5 
<100 
<100 
<100 
<100 
<100 
<100 
<100 
<100 
1
 in pmol 
2
 40 μ\ of a coal tar solution in DMSO was added to 1.96 ml 
S9-mix 
DISCUSSION 
Only one bacterial strain was used in the Salmonella/mi с rosóme 
assay : strain TA98. This strain is very sensitive to mutagens 
derived from polyaromatic compounds. 
It is obvious that liver S9-preparations of rat and man 
show the mutagenic potential of crude coal tar. The human 
capacity to bioactivate the mutagens in coal tar seems to be 
lower than the rat capacity. The same phenomenon has been found 
when model PAH compounds - present in coal tar, like 
3-methylcholanthrene and benzot a)pyrene - were tested with 
activating systems from man and rat [Beaune et al 1985, Raineri 
et al 1986, Tang and Friedman 1977]. The differences of the 
metabolic activation of crude coal tar between human liver 
S9-mix and rat liver S9-mix, however, are smaller than the 
interspecies differences found when an isolated PAH like b(a)p 
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revertants colonies/plate — -
500 1000 1500 
1 - hydroxypyrene (pmol) 
Figure 3.1 A plot of the capacity to activate 
pre-mutagens in coal tar against the capacity to 
hydroxylate the pyrene in coal tar of three human liver S9 
preparations. The mutagenicity was tested in the 
Salmonella/microsome assay towards strain TA98, the 
hydroxylation of pyrene in the parallel assay of 
hydroxylating activity. The regression equation, (95% 
confidence limits of the slope value), the correlation 
coefficient and the number of determinations with 
S9-preparations of each of the donors were : 
donor 1 : Y= -7.7 + 0.16X, (0.14-0.19), r-0.95, n-7, 
donor 2 : Y- -14.7 + 0.15X, (0.14-0.17), r-0.97, n-7, 
donor 3 : Y- -10.7 + 0.17X, (0.16-0.19), r=0.97, n-7. 
Y - number of revertant colonies and χ = 1-hydroxypyrene 
formation in pmol per 2 ml S9-mix. 
is tested. This might be caused by the presence of (low 
concentrations) of amino-PAC in the coal tar. Amino-FAC are 
potent mutagens (Guerin et al, 1980 and Wilson et al 1980). The 
ability of human liver S9-raix to activate amino-PAC like 
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aminoanthracene and aminofluorene is high, compared with rat 
liver S9-mix (Beaune et al, 19Θ5; Neis et al, 1986). The use of 
human liver S9 as an activating system suggest that the human 
genotoxic risk of crude coal tar is lower than measured by the 
standard Salmonella/microsome assay as described by Maron & Ames 
(1983). The differences of the activity of S9 between 
individuals are usually compared using mg protein or pmol P-450. 
This report shows differences in protein and P-450 between 
hepatocytes of individuals. In spite of the difficulty that it 
can not be excluded that the observed data show some variation 
due to variations in the homogenization process, we believe that 
the comparison of pyrene hydroxylase activity and mutagenic 
activation activity in S9-preparations using volume-units of S9 
is allowed, because also protein and cytochrome p-450 show 
variations. 
The variation between the human S9-mix in capacity to activate 
mutagens from coal tar were about б-fold. The activation 
capacity of the S9-mix seemed to be related to the P-450 content 
of the isolated hepatocytes of the same liver sample, as is 
shown by a positive correlation between specific mutagenicity 
and P-450 content (r- 0.93, 95% confidence interval slope value 
- 0.004-0.018, n» 5), but the number of donors was too small to 
test this. 
Although only 2% of the tested crude coal tar consisted of 
pyrene, the pyrene hydroxylase activity was observed in the S9 
preparations of three out of five donors. Large differences of 
the pyrene hydroxylase activity were found. The order of the 
pyrene hydroxylase activity of the S9-mix of three human donors 
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was in correspondence with the mutagenic responses to coal tar 
as measured in the bacterial assay. However, the correlation 
could only be tested for the three S9-preparations which showed 
hydroxylase activity. The correlation suggest that - although 
pyrene itself has not to be considered as a pre-mutagen -
1-hydroxypyrene in vitro may quite well reflect the activation 
of other pre-mutagenic PAC which are present in coal tar. A 
practical consequence of this finding is that it seems to be 
valid that the concentration of 1-hydroxypyrene in urine, as 
found in workers exposed to coal tar derived products 
(Jongeneelen et al, 1985), is not only a parameter of internal 
exposure to pyrene, but may be interpreted in terms of exposure 
to mutagenic tar agents as well. 
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CHAPTER 4 
DETERMINATION OF HYDROXYLATED METABOLITES 
OF POLYCYCLIC AROMATIC HYDROCARBONS IN URINE 
F.J. JONGENEELEN, R.B.N. ANZION and P.Th. HENDERSON. 
Published in: Journal of Chromatography, 413 (19Θ7) 227-232. 
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SUMMARY 
A HPLC method with enzymatic hydrolysis, solid phase sample 
clean up and metabolite specific fluorescence detection is 
presented for hydroxylated-PAH metabolites. 
The method allowed the determination of PAH-metabolites at 
the nmol/1 level. It is shown that coal tar exposed persons 
principally excrete l-hydroxypyrene as a conjugate. 
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INTRODUCTION 
The environmental pollution of polycyclic aromatic hydrocarbons 
(PAH) is widespread [1]. There is sufficient evidence that 
eleven PAH are carcinogenic to experimental animals [2]. 
Industrial operations with high airborne PAH levels like 
gasworks [3,4], cokeworks [5,6,7,8] and aluminium industry 
[9,10] show excess rates of lung cancers. Estimates of the 
health risks due to environmental or occupational exposure to 
these compounds strongly depend on the quality of analytical 
methods to assess the intake or uptake of PAH. 
In this respect, an important role is played by biological 
monitoring i.e. the systematic registration of the exposure 
level of individual workers and groups of workers, measured in 
biological specimens. PAH are metabolized extensively and the 
enzymes involved are classified in two broad categories: phase 
1 enzymes, which catalyse oxidative reactions and phase 2 
enzymes, which catalyse conjugative reactions of oxidized PAH 
with endogenous compounds like sulphuric acid, glucuronic acid 
and glutathione. PAH-metabolites may be excreted either as free 
or as conjugated compounds. 
The known carcinogenic PAH are of a large molecular type 
[2]. For practical reasons we selected three large molecular 
PAH (pyrene, benz(a(anthracene and benzo(a)pyrene) for use as 
indicators. Measurement of hydroxylated metabolites of these 
compounds in urine may be a useful starting point for the 
development of a method for biological monitoring of PAH. 
- 66 -
Adequate analysis of low exposure levels requires the use 
of sophisticated methods. In this note we present a high 
performance liquid chromatographic (HPLC) method with enzymic 
hydrolysis, rapid sample clean up and metabolite specific 
fluorescence detection. This method allowed the determination 
of the sum of free and conjugated hydroxylated PAH in urine at 
the nmol/1 level. It was shown that people exposed to coal tar 
excrete 1-hydroxypyrene principally as a conjugate. 
EXPERIMENTAL 
Chemicals 
Authentic benzol a)pyrene and benz(a)anthracene metabolite 
reference standards were obtained from the NCI Chemical 
Carcinogen Reference Standard Repository, Chicago, USA. 
1-Hydroxypyrene was synthesized by Janssen Chimica, Beerse, 
Belgium. The identity was confirmed with GC-MS and NMR. 
ß-glucuronidase/aryl sulphatase (100.000 Fishman U/ml and 
800.000 Roy U/ml) was obtained from Boehringer, Mannheim, FRG. 
HPLC-grade methanol was from Fisons, Loughborough, England. 
HPLC-grade water (conductivity > 18 MOhm/cm) was generated from 
distilled water by a water purification system (Millipore, 
Milford, USA). All other chemicals were of the highest purity 
obtainable. 
Enzymic hydrolysis 
An aliquot of urine (10-25 ml) was adjusted to pH 5.0 with 1.0 N 
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HCl and 0.1 H acetate buffer (pH 5.0) was added to a total 
volume of 30 ml. This mixture was incubated overnight (16 h) 
with 12.5 μί ß-glucuronidase/aryl sulphatase at 37°C in an 
electronically controlled rotary shaking bath (210 r.p.m.). 
Extraction procedure 
A sample enrichment and purification cartridge packed with C-18 
reversed phase liquid chromatographic material (sep-рак C-18 
cartridge. Waters, Hilford, USA) was used for the extraction of 
the metabolites. After priming the cartridge with 5 ml 
methanol, followed by 10 ml distilled water the hydrolysed 
sample passed the cartridge at ca. 10 ml/min. Subsequently the 
cartridge was washed with β ml distilled water. Retained 
solutes were eluted with 10 ml methanol. The solvent was 
evaporated at 60°C under a gentle flow of nitrogen and the 
residue was dissolved in 2.0 ml methanol. 
Calibration procedure 
Samples of hydrolysed urine of non-exposed persons (blank 
urines) were spiked with the given analyte. These calibration 
samples were treated as written in the extraction procedure. At 
least five different concentrations across the working range 
were measured in duplo. Calibration curves were calculated with 
the least squares method. Reagents blanks were used to monitor 
for interferences. 
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Reversed phase HPLC analysis 
The analyses were conducted on a HPLC gradient system controlled 
by a microprocessor (Kipp Analytica, Kipp & Zn, Delft, Holland). 
A fully automatic sample injector (Kipp Analytica) filled a 
20 μΐ sample loop valve under slight pressure from sealed 2 ml 
vials and injected it subsequently on a 150*4 mm ID Lichrosorb 
HP 18 (5 цш) column (Merck, Darmstadt, FRG). The column 
temperature was ICC, the flow 0.8 ml/rain. The solvent gradient 
was as follows: 5 min 46/54% methanol/water, a linear gradient 
to 94/6% methanol/water in 35 min; hold for 10 min. The 
Chromatograph was equipped with a fluorescence spectrophotometer 
(Perkin Elmer, type LS 4). The excitation and emission slits 
were both set on 5 nm. 
Table 4.1. Excitation ( Aex) and emission wavelengths (Xem) 
metabolite xex(nm) Aem(nm) 
1-hydroxypyrene 242 388 
3-hydroxy-benz(a)anthracene 290 402 
3-hydroxy-benzo(a)pyrene 265 430 
Throughout the chromatographic analysis three pairs of 
programmed excitation and emission wavelenghts were set by the 
microprocessor prior to the peak appearing. Because the pair of 
wavelenghths can be changed during the run, it is possible to 
measure several HPLC separated metabolites with optimum 
sensitivity and selectivity. The wavelenghts used in this assay 
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are listed in table 4.1. Peak heights were used for 
quantification. 
RESULTS AND DISCUSSION 
Table 4.II. Enzymatic hydrolysis of 1-hydroxypyrene conjugates 
in urine from three coal tar exposed patients* 
incubation 1-hydroxypyrene //mol/1 
time (h) patient 1 patient 2 patient 3 
0 1.1 0.4 0.6 
0.5 Θ.1 1.4 1.8 
1.0 13.3 1.6 2.4 
2.0 14.1 1.6 2.4 
4.0 13.3 1.7 2.4 
6.0 13.3 1.7 2.6 
24.0 12.4 1.5 2.5 
* The experiments were performed with 2 ml aliqouts of urine 
diluted with buffer to a volume of 30 ml in the presence of 
12.5 //1 Q-glucuronidase/arylsulfatase solution. 
The optimum incubation conditions for the enzymic 
hydrolysis of glucuronide- and sulphateconjugates of 
PAH-metabolites were determined with urine samples of three 
female dermatological patients undergoing coal tar treatment. 
These patients excreted 1-hydroxypyrene after topical 
application of a 10% coal tar ointment [11]. Table 4.II shows 
that the level of 1-hydroxypyrene increased 7-9 fold after 
enzymic hydrolysis. It was found that an incubation time of two 
hours is enough to hydrolyse the 1-hydroxypyrene conjugates. 
Nevertheless, a much larger incubation time (16 h) was chosen 
for the determination of urinary PAH-metabolites to be sure that 
the other conjugated metabolites were also hydrolysed. It 
appeared that 6.25 μΐ of enzyme solution gave equal results. 
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Again, an excess of enzyme solution was used (12.5 μ!) for the 
hydrolysis of all conjugated metabolites. 
The HPLC analysis for the separation of PAH-metabolites is 
essentially based on the reversed phase separation generally 
applied in studies of the metabolism of PAH [12,13,14,15,16]. 
Units of fluorescence • 
и
 y w ' - V M a ^/-o f | '"/.30 
^-1-OH-PYRENE 
y- 3 ОН В (О) A 
^ Э OH Bl«) Ρ 
/ C 
- J V ~ в 
, A 
0 10 20 30 40 50 
time (mm) 
Fig. 4.1. HPLC-chromatograms of extracts from a blank urine (A), 
a blank urine spiked to contain ca. 400 nmol/l of each 
of the three hydroxylated PAH (B) and a urine sample 
from a worker exposed to creosote, a PAH containing 
wood preservative (C). 
Reversed phase analysis of hydroxylated PAH metabolites in 
urine was very satisfactory because of a high resolution and a 
low level of interfering compounds. In the present study it was 
found that metabolite-specific fluorescence detection maximized 
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the sensitivity and minimized interferences, resulting in a 
non-laborious extraction procedure. Figure 4.1 shows 
chromatograms of a non-exposed person (blank urine), of the 
blank urine spiked with three PAH-metabolites, and a 
chromatogram of a urine sample from a PAH-exposed worker at a 
creosote plant. 
The urine of workers exposed to PAH showed levels of 
1-hydroxypyrene up to 1500 nmol/1 [11,17]. The recovery of the 
analyte was determined in spiked urine samples at three 
concentrations (40, 200 and 400 nmol/1). The mean recovery (SD) 
from four determinations was 88 (9.0), 83 (4.4), 84 (2.9), 
respectively. The calibration curves for 1-hydroxypyrene were 
set up in hydrolysed urine across the working range (ca. 0, 10, 
20, 40, 400 and 800 nmol/1 in duplo). The standard curves were 
linear with a correlation coefficient of at least 0.99. The 
y-intercept of the curve was not significantly different from 
zero at the 95% confidence level. The detection limit of 
urinary 1-hydroxypyrene was 0.5 nmol/1 (signal/noise > 4), 
assayed with an autosampling and auto-injection system using 
2 ml vials. Manual injection allowed the manipulation of more 
concentrated samples and decreased the detection limit with a 
factor 10. 
The present method offers the possibility to measure more 
metabolites in one run by setting the optimum excitation and 
emission wavelengths at the corresponding retention times. It 
is probable that PAH exposed workers excrete other metabolites 
of PAH. Attempts were made to measure 
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3-hydroxy-benz(a)anthracene and 3-hydroxy-benzo(a)pyrene in 
workers' urine, but so far these metabolites were not 
detectable, just as when other extraction techniques were 
applied. The detection limit of 3-hydroxy-benz(a)anthracene and 
3-hydroxy-benz(a)pyrene was 5.0 and 4.0 nmol/1, respectively. 
Now the attention has been focused on the identification of 
other hydroxylated metabolites. 
A bulk urine sample was spiked with 180 nmol/1 
1-hydroxypyrene. The urine was divided in aliquots of 20 ml and 
stored at - 18CC. In the course of 12 months 24 aliquots were 
assayed. No losses of 1-hydroxypyrene were recorded during this 
period. The long term stability of 1-hydroxypyrene in urine is 
good. The average concentration in these 24 determinations was 
167 nmol/1 and the relative standard deviation (- coefficient of 
variation - CV) was 12.6%. The latter may be used as an 
estimation of the random error of 1-hydroxypyrene analyses. 
The analytical potential for 1-hydroxypyrene appeared to 
work out well across the working range. Mathieu et al [18] did 
not apply a hydrolysis step at all in the analytical method of 
trace amounts of urinary benzo(a)pyrene-metabolites. Keimig et 
al [19] reported that initial treatment of urine with heat and 
strong acid to hydrolyse 1-hydroxypyrene conjugates did not 
increase the yield. The results of the present study however 
show that 1-hydroxypyrene is principally excreted as a 
conjugate. The enzymic hydrolysis appeared to be very effective 
and neccesary in measuring trace amounts of FAH-metabolites in 
urine at the nmol/1 level. The urine samples can be stored for 
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at least a year without losses of 1-hydcoxypycene. 
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ABSTRACT 
A method for the monitoring of exposure to benzo(a)pyrene was 
applied to rat urine samples. Benzo(a)pyrene was administered 
orally and was applied on the dorsal skin in repeated doses of 
10, 20 and 50 ¿«nol/kg body wt. At low dose levels, the urinary 
excretion of 3-OH-benzo(a(pyrene was higher after percutaneous 
treatment than after oral administration. The excretion of four 
benzo(ajpyrene metabolites, including 3-OH-benzo(a)pyrene, was 
faster after oral administration. The percutaneous absorption 
of small doses of benzo(a)pyrene appeared to be greater than the 
oral absorption. 
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INTRODUCTION 
Exposure to polycyclic aromatic hydrocarbons (PAH) such as 
beiizo(a)pyrene is associated with elevated cancer rates for 
several tissues of epithelial origin [61. Several groups of 
people working with coal tar or coal-tar related products are 
exposed to PAH. The airborne concentration of PAH in various 
industrial operations has been described extensively [2,3,6], 
but cutaneous penetration has received little attention and was 
only described after coal tar treatment of dermatologie patients 
[5]. A group of psoriatic patients, undergoing treatment with 
coal tar and ultra violet light, revealed an increased urinary 
excretion of mutagens [10]. After topical application of 
creosote, a coal-tar distillation product, mutagens appeared in 
urine of rats. However, no increase in mutagenic components 
could be detected in the urine of creosote workers [4]. 
We have recently reported a sensitive method for the 
monitoring of benzot a)pyrene intake by means of the measurement 
of 3-OH-benzo(a)pyrene in urine [7]. The subject of this paper 
is the quantitation of the relative importance of percutaneous 
uptake of benzo(a)pyrene in relation to oral absorption in rats. 
MATERIAL AND METHODS 
Chemicals 
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Benzol a)pyrene was purchased from Aldrich Europe (Beerse, 
Belgium). ß-Glucuronidase/aryl-sulfatase was obtained from 
Boehringer (Mannheim, F.R.G.). The authentic 
3-hydroxy-benzo(a)pyrene metabolite used as a reference standard 
was obtained from the NCI Chemical Carcinogen Reference Standard 
Repository. All other chemicals used were of the highest purity 
obtainable. 
Animals 
Hale Wistar rats, weighing 200-250 g, were housed individually 
in stainless steel metabolism cages, designed for the separate 
collection of urine and faeces. The rats had free access to 
water and food. Four groups of three rats were treated orally 
with 0, 10, 20 and 50 //mol of benzo(a)pyrene/kg body weight, 
respectively, suspended in 0.2 ml olive-oil, for three 
consecutive days. The total doses were 0, 30, 60, and 150 
//mol/kg, respectively. Twenty-four-hour urine samples were 
collected for six days (beginning on the first day of 
administration) and frozen until required. 
Four other groups of three rats received 0, 10, 20, and 50 
umol benzo(a)pyrene/kg bodyweight, suspended in 0.1 ml 50/50 % 
olive-oil/acetone, via topical application to + 4 cm2 of the 
clipped dorsal skin for three consecutive days. The total doses 
were 0, 30, 60, and 150 //mol/kg, respectively. To prevent 
contamination by the chemical falling off or being removed from 
the skin surface of the animals in the metabolism cages, the 
treated area was protected with Al-foil, covered with a suede 
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rat jacket. Twenty-four-hour urine samples were collected for 
six days and frozen until required. 
Isolation of benzo(a)pyrene metabolites 
After dilution to 20 ml, 10 ml of a diluted 24 h rat urine were 
adjusted to pH 5.0 with 4.0 N HCl and buffered with 5 ml 0.1 M 
acetate buffer (pH 5.0). It was incubated overnight with 12.5 
μΐ of ß-glucuronidase/aryl sulfatase (1250 U) at 370C. A 
Sep-рак C18 cartridge was used for the isolation of metabolites 
of benzo(a)pyrene. After priming the cartridge with methanol (5 
ml), followed by water (aqua dest, 10 ml), the hydrolyzed sample 
passed the cartridge at a rate of approximately 10 ml/min. 
Subsequently the cartridge was washed with water (aqua dest, θ 
ml). Retained solutes were eluted using 10 ml methanol. The 
solvent was evaporated at 60"C under a constant flow of nitrogen 
and the residue was dissolved in 1.0 ml methanol. 
HPLC analysis 
Analyses were performed with a Kipp Analytica HPLC unit, 
equipped with two solvent pumps (model 920Θ), a solvent 
programmer (model 9224), an automatic sampler (model 9209) and a 
column thermostat (model 9222). Using a sample loop, an aliquot 
of 20 μΐ was injected into a 150 χ 4.6 mm i.d. Lichrosorb RP18 
(5 //m) column (column temperature was 40°C, flow 0.8 ml/min). 
The following solvent program was used : 5 min solvent A ( 60% 
water/40% methanol), a linear gradient to 90% solvent В (100% 
- 80 -
methanol) in 35 min, followed by 17 min 90% solvent B. A Perkin 
Elmer type 3000 fluorescence spectrophotometer with a 16 μϊ 
flowcell was used for detection. Excitation wavelength was 265 
nm, emission wavelength 430 nm. Slits were 5 nm. The detection 
limit for 3-0H-benzo(a)pyrene was 20 pg. 
The coefficient of variation (CV) of the determination of 
3-OH-benzo(a)pyrene in urine was 16 % (n = 5). 
RESULTS 
Figure 5.1 shows the cumulative excretion of 3-OH-benzo(a)pyrene 
and its conjugates in urine of rats, after treatment with three 
doses: 3 χ 10, 3 χ 20 and 3 χ 50 ¿/mol/kg. None of the blank 
urine samples revealed 3-OH-benzo(a)pyrene (detection 
limit < 1 ng/24h). After topical treatment, 3-OH-benzo(a)pyrene 
appeared much later than after oral administration. The 
repeated administration was not clearly reflected in the 
excretion pattern of 3-OH-benzo(a)pyrene. Table 5.1 compiles 
the total recovery of 3-OH-benzo(a)pyrene in six consecutive 24 
hrs urine samples. It is remarkable that the percentage of the 
dose recovered as 3-OH-benzo(a)pyrene after cutaneous 
penetration was the highest at the lowest dose applied. 
HPLC-analysis did not only reveal 3-OH-benzo(a)pyrene 
(metabolite IV), but also three benzo(a)pyrene-metabolites (I, 
II and III), which have not yet been identified. According to 
the retention volumes, these metabolites may include a 
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3-0H-B(a)P(>jg) 
35-1 
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Fig . 5 . 1 : Cumulative u r inary 3-0H-benzo(a)pyrene excre t ion 
of r a t s during s ix days a f t e r 3x admin i s t r a t ion of 
10 (Δ Δ ) , 20 (G D) and 50 /mol of B(a)P/kg 
(O O ) . 
Each point represents the mean value of 3 rats. Arrows 
under the figure indicate the time of administration of 
benzo(a)pyrene ( ), topical treatment ( ), oral 
administration. 
dihydrodiol-benzo(a)pyrene and/or a trihydrotriol-benzo(a)-
pyrene. The urinary excretion of the four benzo(a)pyrene 
metabolites was followed for six days. Fig. 5.2 shows a rapid 
and dose dependent response of all four metabolites after oral 
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administration. After topical treatment the metabolites 
appeared later. The excretion pattern of 3-0H-benzo(a)pyrene is 
similar to those of the other three metabolites. 
TABLE 5.1: CUMULATIVE EXCRETION OF 3-OH-BENZO(a)PYRENE IN URINE 
OF RATS AFTER ORAL AND PERCUTANEOUS ADMINISTATION OF 
REPEATED DOSES OF BENZO(A)PYRENE 
Dose of Administration 
benzo(a)pyrene oral percutaneous 
pmol/kg ¿ig* % dose //g* % dose 
3 χ 10 5.6 + 2.5 0.29 10.8 ± 1.5 0.56 
3 χ 20 8.3 + 0.7 0.22 11.0 ± 2.2 0.29 
3 χ 50 33.7 ± 13.5 0.35 21.0 + 0.7 0.22 
* Mean of groups of three rats ± SEN 
DISCUSSION 
Reversed phase HPLC analysis of urine concentrate of treated 
rats revealed four peaks ( I, II, III and IV), most likely 
benzo(a)pyrene metabolites. Metabolite IV was characterized as 
3-OH-benzo(a)pyrene [7]. The urinary excretion patterns of the 
four metabolites suggest different elimination kinetics after 
oral and percutaneous administration. 
When metabolism cages are used, a problem of considerable 
importance is that of contamination of the urine by the chemical 
falling off or being removed from the skin surface. In spite of 
the application of a skin cover, HPLC analyses revealed 
unmetabolized benzot a)pyrene in urine, but only in urine samples 
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Fig. 5.2: Urinary excretion of metabolites I ( ), II (- - - ) , 
III ( ·-•) and IV ( ) during six days, after three 
administrations of 10 (fig. a and fig. b), 20 (fig. с 
and fig. d) and 50 /mol of benzo(a)pyrene/kg body wt 
(fig. e and fig. f). The maximal excretion of each 
metabolite in 24 hrs as monitored in fluorescence units, 
was converted to 100 All other values, irrespective 
of dose, are related to the point of maximal excretion. 
Each point represents the mean of 3 rats. Arrows under 
the figure indicate the time of administration. On the 
left а, с and e show the excretion pattern after oral 
administration and on the right b, d and f show the 
excretion pattern after percutaneous administration. 
of skin treated animals. Quantities of benzo(a)pyrene recovered 
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in urine were never higher than 0.03% of the dose. None of the 
urine samples of orally treated rats contained measurable 
amounts of benzo(a)pyrene (< 1 ng/24 hrs). The unmetabolized 
benzo(alpyrene in urine samples of percutaneously treated 
animals plotted against time revealed a capricious pattern, 
differing from rat to rat and was not related to the 
administered dose. Therefore the benzo(a)pyrene recovered in 
urine samples was most likely caused by contamination with the 
chemical falling off or being removed together with skin flakes. 
An important point in this study is the high skin 
penetration capacity as illustrated in table 5.1. After topical 
administration of benzo(a)pyrene at doses of 480 and 960 /yg/cm2, 
equivalent to 3 χ 10 and 3 χ 20 //mol/kg, respectively, the 
cumulative elimination by excretion of 3-OH-benzo(a)pyrene and 
its conjugates is larger than after an equal oral dose, although 
the absorption surface of the gastro-intestinal tract is much 
larger. 
After percutaneous penetration, excretion of four 
metabolites hardly increased with the dose, as is illustrated in 
figs. 5.2b, 5.2d and 5.2f. The excretion of 
3-OH-benzo(a)pyrene was relatively high following the lower dose 
(table 5.1). A similar inverse relationship has also been found 
after topical treatment with different doses of hydrocortisone, 
benzoic acid and testosterone in rhesus-monkeys and man (11]. 
Recently, Sanders et al reported the same phenomenon after 
percutaneous absorption of [14C]-benzo(a)pyrene in mice [9]. It 
is obvious that small quantities of benzol a)pyrene penetrate 
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very effectively through the rat skin. 
Cutaneous penetration depends largely upon the nature of 
the penetrant and is mainly a function of solubility and 
diffusion. In addition, many other factors are affecting 
cutaneous absorption like skin site, temperature, peripheral 
circulation, species and dose. Cutaneous absorption of several 
compounds in different species, e.g. rats, rabbits, miniature 
swine and man, showed a high permeability of rabbit skin, 
followed closely by rat skin. Although the permeability of 
human skin is up to ten times lower [1], occupational exposure 
to PAH via the skin must not be neglected. Work is now in 
progress to study possibilities for the estimation of human 
exposure after skin contact with benzo(a)pyrene containing 
products, via the measurement of urinary 3-OH-benzo(a)pyrene. 
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ABSTRACT 
3-0H-benzo(a)pyrene (З-ОН-В(а)Р) and mutagenic activity in rat 
urine were determined after the oral administration of 
benzo(a)pyrene given in three repeated doses of 10, 20 or 50 
jumol/kg. The procedure for the determination of 3-OH-B(a)P 
consisted of enzymatic hydrolysis, separation and HPLC-analysis. 
The mutagenic activity of concentrated urine samples was assayed 
with the Salmonella typhimurium strain ΤΑ9Θ in the presence of 
S9 mix and ß-glucuronidase. The urinary excretion of 3-OH-B(a)P 
and urinary mutagenicity showed a good correlation and both 
parameters showed a dose-response relationship. Data indicated 
that 3-OH-B(a)P can be regarded as a reliable representative of 
all urinary (pre)-mutagens derived from B(a)P and exposure of 
rats to B(a)P could be detected with greater sensitivity by the 
HPLC assay of 3-OH-B(a)P than with the non-specific mutagenicity 
assay. 
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INTRODUCTION 
Exposure to polycyclic aromatic hydrocarbons (PAHs) such as 
benzo(a)pyrene (B(a)P) is associated with elevated cancer rates 
for several tissues of epithelial origin, in particular the skin 
and lung (1). Many groups of workers are exposed to PAHs (2). 
For the routine monitoring of workers, different approaches are 
reported. A non-selective way to quantify the internal exposure 
is the measurement of urinary mutagenic activity. This 
monitoring method was tested at several industrial operations 
with possible exposure to FAHs with conflicting results (3-5). 
The significance of these studies of exposed workers is limited 
because of a lack of actual exposure data. Recently, Clonfero 
et al. (6) reported exposure data of PAHs in combination with 
urinary mutagenicity of exposed workers. No elevated 
mutagenicity levels were measured despite exposure to B(a)P at a 
concentration of 1.4 //g/m'. 
Apparently, to detect low levels of exposure, the urinary 
mutagenicity assay is not sensitive enough. Possibly, another 
way of occupational exposure assessment is to measure the 
urinary excretion of PAHs or their metabolites. A contaminated 
work environment may contain a mixture of different PAHs (7). 
Because the highly carcinogenic B(a)P always appears to be 
present in such mixtures, this compound may be taken as a marker 
of exposure to FAHs. Workers exposed to a mean concentration of 
63 μq/m' B(a)P excreted higher concentrations of UV-absorbing 
material, presumably B(a)P, in urine voided after work than the 
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next morning (8). However, exposure is much lower in most 
industrial settings and, the conversion of B(a)P to a large 
number of metabolites decreases the urinary excretion of 
unmetabolized B(a)P to an extremely low level. 
An alternative approach is to determine the metabolites of 
B(a)P. This paper describes a sensitive method for the 
measurement of 3-0H-B(a)P, a major metabolite of B(a)P in rat 
urine. This method was used to study whether there is a 
relationship between the urinary excretion of 3-0H-B(a)P and the 
urinary mutagenic activity. 
EXPERIMENTAL 
Chemicals 
B(a)P was purchased from Aldrich Europe, Beerse, Belgium. 
ß-Glucuronidase/aryl sulphatase was obtained from Boehringer 
Mannheim. Authentic B(a)P metabolite reference standards were 
obtained from the NCI Chemical Carcinogen Reference Standard 
Repository. All other chemicals used were of the highest purity 
obtainable. 
Animals 
SPF male Wistar rats weighing about 200-250 g were housed 
individually in stainless-steel metabolism cages, designed for 
the separate collection of urine and faeces. The rats had free 
access to water and food. Four groups of three rats were orally 
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administered, 0, IO, 20 and 50 //mol B(a)P per kg body weight, 
suspended in 0.2 ml olive-oil, respectively for three 
consecutive days. The total doses of B(a)P were 0, 30, 60 and 
150 ¿/raol/kg, respectively. Twenty-four hour urine samples were 
collected for six days (beginning at the first administration) 
and frozen until required. 
Before analysis, rat urine samples were filled up to 20 ml 
with water and split up into two portions of 10 ml, one for the 
B(a)P metabolite analysis and one for the urinary mutagenicity 
assay. Another four groups of three rats in metabolism cages 
were orally administered 0.01, 0.1, 0.5 and 5 ¿/mol B(a)P per kg 
body weight in 0.2 ml olive-oil in a single dose. Twenty-four 
hour urine samples were collected on the day before 
administration, the day of administration and the next 2 days. 
These urine samples were assayed only for B(a)P metabolites. 
Mutagenicity testing 
Half of a 24-h urine sample (10 ml) was loaded on an Amberlite 
XAD-2 column with a 4 cm1 bed volume. The column was washed 
three times with 5 ml aqua dest. The adsorbed material was 
eluted with 10 ml acetone. The eluate was evaporated to dryness 
under nitrogen at 60°C and the residue was dissolved in 0.35 ml 
of dimethylsulphoxide. From the solvent extract 0.1 ml per 
plate was assayed for mutagenicity with the Salmonella 
typhimurium strain ΤΑ9Θ in the presence of 0.5 ml S9 mix and 
0.1 ml of a sterile ß-glucuronidase solution (1500 U/ml). The 
S9 mix was prepared according to Maron and Ames (9) and 
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contained 100 μΐ per ml of a hepatic 9000xg supernatant from 
Aroclor 1254 induced rats and a NADPH-generating system. 
Every sample was determined in triplicate. After 48 h 
incubation at 370C the revertant colonies were counted. 
Pretreatment of the rat urine 
The other half of 24-h urine sample (10 ml), adjusted to pH 5.0 
with 4.0 N HCl and buffered with 5 ml 0.1 M acetate buffer 
(pH 5.0), was incubated overnight with 12.5 μΧ 
ß-glucuronidase/aryl sulphatase (1250 U) at 37°C. 
A Sep-рак CIS cartridge was used for the separation of PAH 
metabolites. After priming the cartridge first with 5 ml 
methanol, then with 10 ml aqua dest, the hydrolysed sample was 
drawn through the cartridge at a rate of approximately 10 ml per 
min. Subsequently the cartridge was washed with 8 ml aqua dest. 
Retained solutes were eluted using 10 ml methanol. The solvent 
was evaporated at 60oC under nitrogen and the residue dissolved 
in 1.0 ml methanol. 
Reversed-phase HPLC analysis 
Analyses were performed with a Kipp Analytica high pressure 
liquid Chromatograph (HPLC) equipped with two solvent pumps 
(model 9208), a solvent programmer (model 9224), an automatic 
sampler (model 9209) and a column thermostat (model 9222). 
Using a sample loop, a 20 μΐ aliquot was injected on a 150 χ 4.6 
- 93 -
mm ID Lichrosorb НРІ (5 pm) column. Column temperature was 
40eC, flow 0.8 ml per min. The following solvent programme was 
commenced: 5 m m 90% solvent A (60% bidest, 40% methanol), a 
linear gradient to 90% solvent В (100% methanol) in 35 mm, 
followed by 17 min 90% solvent B. Fluorescence detection was 
performed with a Perkin Elmer type 3000 spectrofluorometer with 
a 16 μΐ flowcell. Excitation wavelength (^ex) was 265 nm, 
emission wavelength (*em) 430 nm. The eluate was subjected to 
excitation scanning with the flow stopped, at лет - 430 nm and 
to emission scanning at e^x - 265 nm with both slits on 5 nm. 
The detection limit of 3-OH-B(a)P was 20 pg or with a sample 
loop of 20 μΐ, 1 /jg/l. Peak heights were used for 
quantification. 
RESULTS 
Excretion of 3-OH-benzo(a)pyrene and other hydroxylated 
metabolites 
Reversed-phase HPLC analysis of urine samples of treated and 
untreated rats revealed several peaks. Two peaks in the 
chromatogram of the treated animals coincided under identical 
conditions with authentic standards of two metabolites: viz. 
3-OH-B(a)P and 4,5-diol-B(a)P. Figure 6.1 shows representative 
chromatograms of urine samples of one treated an one untreated 
animal and also a mixture of five reference compounds. 
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Fig. 6.1. High-pressure liquid chromatogram analyses of urine of 
a non-treated rat and a rat treated with benzo(a)-
pyrene. The lower solid line represents the untreated 
rat. The upper solid line shows a chromatogram of a 
urine sample of a treated rat. The broken line re-
presents fluorescence of 6 benzo(a)pyrene references. 
9,10-Diol-B(a)P - 9,10-dihydrodiol benzo(a)pyrene; 
4,5-diol-B(a)P - 4,5-dihydrodiol benzo(a) pyrene; 
7,8-diol-B(a)P - 7,8-dihydrodiol benzo(a)pyrene; 
9-0H-B(a)P = 9-hydroxybenzo(a)pyrene; 
3-OH-B(a)P - 3-hydroxybenzo(a)pyrene; 
B(a)P « benzo(a)pyrene. Metabolites I, II, and III are 
unidentified benzo(a)pyrene-metabolites, metabolite IV 
is characterized as 3-hydroxybenzo(a)pyrene. 
Recovery of the metabolites, using an analytical column, 
permitted characterization by fluorescence excitation and 
emission scans. Figure 6.2 shows the excitation and emission 
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Fig. 6.2. Fluorescence (a) emission and excitation scan (b) of 
3-hydroxy-benzo(a)pyrene and peak IV of figure 6.1 
(broken line). The conditions are described in the 
Experimental section. 
spectra of the 3-0H-B(a)P reference standard and the 
corresponding peak of the Sep-pak CIS urine eluate of a treated 
rat (peak IV in figure 6.1). Reference compounds as well as 
urinary metabolites were scanned under similar conditions, i.e. 
in water/methanol mobile phase. Both the excitation and 
emission spectrum agreed with those of the authentic standard. 
Figure 6.3 shows a good agreement of excitation and emission 
scans of the 4,5-diol-B(a)P reference and the possible urinary 
metabolite. 
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Units of 
fluorescence 
X30 
300 Д00 500 300 Д00 
Wave length ( nm ) 
Fig. 6.3. Fluorescence emission (a) and excitation scan (b) of 
4(5-diol-benzo(a)pyrene and the corresponding peak in 
the chromatogram in figure 6.1 (broken line). 
The conditions are described in the Experimental 
section. 
Peak II does not have the fluorescence characteristics of 
^lO-diol-BfaJP, nor does peak III agree with the 7,8-diol-B(a)P 
reference. The B(a)P metabolites I, II and III have not been 
characterized yet. 
The accuracy of the separation of the hydrolysed 
metabolites was determined with a human urine sample spiked with 
3-0H-B(a)P (10 //g/1) and 4,5-diol-B(a)P (50 //g/1). The recovery 
of both metabolites was determined in five analyses. The mean 
(+ SD) yield was 43 + 7.2% and 97 + 1.1%, respectively. The 
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reproducibility, expressed as a coefficient of variation (CV), 
of 3-0H-B(a)P assay was 16%. 
3-OH-B(a)P 
(¿jg/SAh) 
20 
A 5 6 
Time (days ) 
Fig. 6.4. Urinary excretion of 3-hydroxy-benzo(a)pyrene after 
oral administration of 3χ10(Δ Δ) 3X20(0 α) 
and 3x50(0 O) //mol/kg benzo(a)pyrene. Each 
point represents the mean + SD value of three rats. 
Arrows indicate the tine of administration. 
In order to study the excretion pattern of B(a)P 
metabolites, rats were administered three times a relatively 
high dose of B(a)P. Figure 6.4 shows the 24-h urinary excretion 
of 3-0H-B(a)P for six days after oral administration. It shows 
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a clear dose-dependent excretion of 3-0H-B(a)P. The relatively 
large SD values were not caused by lack of accuracy, but by 
individual variation in urinary 3-0H-B(a)P excretion. 
4,5-Diol-B(a)P was excreted approximately ten times less than 
3-0H-B(a)P. 
Revert ant colonies/plate 
800- r 
600 
Д00-
200 
ι ι 1 I 1 I 
1 2 3 A 5 6 
t t t Time (days) 
Fig. 6.5. Urinary excretion of mutagens during six days as 
detected with the Salmonella typhimurium assay after 
3x50(0 О), 3x20(0 α), 3Χ10(Δ Δ) and zero 
(ν ν) /smol per kg benzo(a)pyrene administration. 
Each point represents the mean + SD value of three 
rats. Arrows indicate time of administration. 
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Urinary mutagenicity 
The same urine samples, analysed for the hydroxylated B(a)P 
metabolites, were concurrently subjected to the mutagenicity 
assay. The results presented in figure 6.5 show that the 
excretion of mutagens is dose-dependent. 
3-OH-B<a)P(>jg/24h) 
200 
τ 1 1 r 
400 600 Θ0Ο 
Resertant colonies / plate 
Fig. 6.6. Correlation of the urinary mutagenicity assay and 
parallel analyses of 3-hydroxy-benzo(a)pyrene of 
24-h urine samples of six days at three levels: 
3x50 (O), 3x20 (Q) and 3x10 (Δ) //mol benzo(aIpyrene 
per kg body weight. Each point represents the 
excretion of 3-hydroxy-benzo(a)pyrene and mutagens 
of one rat (n-47). 
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These mutagenicity values probably reflect not only the 
presence of 3-0H-B(a)P but also the excretion of several other 
mutagenic metabolites. In order to find out whether 3-0H-B(a)P 
was representative of the total amount of mutagenic 
B(a)P-metabolites, the urinary concentrations of this compound 
were compared with the mutagenic activity of the same urine 
samples (figure 6.6). Urine samples with a revertant score 
lower than 72 (-mean background + 2xSD) were rejected for the 
regression analysis. Exponential regression resulted in the 
best fit: 
μ<3 З-ОН-В(а)Р) per 24-h 
- 0.4 * exp (4.8 χ 10-3 (revertant colonies - 54)} (1). 
The Spearman's coefficient of rank correlation was r
s
 - 0.95 
(n - 39, P< 0.0001). 
Table 6.1. Cumulative excretion of 3-hydroxy-benzo(a)pyrene in 
urine after oral administration of different doses of 
benzo(a)pyrene to the rat 
Dose benzo(a)-
pyrene (nmol per 
kg bodyweight)1 
Cumulative urinary 
excretion in 6 days 
Cumulative urinary 
excretion in 3 days 
ftq)'· % dose ng) : % dose 
(Эх) 50.000 
(3x) 20.000 
(3x) 10.000 
(lx) 5.000 
(lx) 500 
(lx) 50 
(lx) 10 
33.6 + 
8.3 + 
5.6 + 
13.5 
0.7 
2.5 
0.35 
0.22 
0.29 
367 + 
100 + 
25 + 
14 + 
117 
35 
7.6 
7.5 
0.11 
0.32 
0.78 
2.3 
)' The high doses were given repeatedly (at three consecutive 
days). The relatively low doses were given once. 
) 2 Mean + SD of groups of three animals. 
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Sensitivity of the 3-0H-benzo(a)pyrene assay 
In estimating the detection limit of 3-0H-B(a)P and its 
conjugates in urine, rats were orally administered relatively 
low, single doses of B(a)P. The cumulative excretion of 
3-0H-B(a)P in urine collected for six or three days, after 
repeated high and single low dose, respectively, is summarized 
in Table 6.1. At the end of the sampling periods excretion of 
3-0H-B(a)P was negligible (< 1 ng daily). Table 6.1 compiles an 
excretion of 0.1-2.3% of the dose as 3-OH-B(a)P and its 
conjugates after oral administration. An oral dose of 
50 nmol/kg (about 3 μg per rat) was easily detectable by the 
3-OH-B(a)P assay. 
Profile of benzo(a)pyrene metabolites in urine 
Figure 6.7(a)-(d) show the dose- and time dependence of the four 
B(a)P metabolites I, II, III and IV. Metabolites I, II and III 
are unidentified, metabolite IV is 3-OH-B(a)P. The highest 24-h 
excretion of each metabolite, observed after the highest dose 
was converted to 100%. All the other values, irrespective of 
dose, are related to this point of maximal excretion. It can be 
noticed that the excretion of the four metabolites had the same 
excretion pattern and consequpntly the urinary excretion of 
3-0H-B(a)P does not differ much from the other three 
metabolites. This indicates that the dose or time elapsed after 
exposure has no significant effect on the ratio of metabolites. 
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DISCUSSION 
After enzymatic hydrolysis of the glucuronic acid conjugates and 
sulphate conjugates, the main metabolites found in urine of rats 
treated with B(a)P were 3-0H-B(a)P and 4,5-diol-B(a)P. These 
are also major metabolites in rat bile (10) and are major 
products formed by rat hepatocytes (13). 
Relative 
fluorescence units 
(%) 
100 
100 π с 
1 2 3 U 
î t t 
5 6 1 2 3 U 5 6 
t t t Time days 
Fig. 6.7. Urinary excretion kinetics of four benzo(a)pyrene 
metabolites I (a), II (b). III (c) and 3-hydroxy-
benzo(a)pyrene (d) after oral administration of 
3Χ10(Δ Δ), 3χ20(α о) and 3x50(0 о) 
//mol/kg. Each point represents the mean value 
of three rats. Arrows indicate the time of 
administration. 
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Studies with radio labelled B(a)P indicate that B(a)P 
metabolites are mainly excreted in the faeces and only a minor 
part (5-15%) is excreted in urine (11,12). This report shows 
that after oral administration 0.1-2.3% of the dose was excreted 
in urine as 3-OH-B(a)P and its conjugates. The lower is the 
single dose, the larger is the percentage of the dose excreted 
as 3-OH-B(a)P. The situation with multiple doses is more 
complex, because of a probable induction of metabolizing 
enzymes. 
The large variation between rats in our experiments is not 
due to a low accuracy. It must depend on variation in the B(a)P 
metabolism. However, this variation did not affect the profile 
of B(a)P metabolites. 
In two different non-induced mice strains an excretion of 
0.002-0.004% of the dose of B(a)P was found as 3-OH-B(a)P after 
intra-peritoneal injection (14). The large difference with our 
results illustrates the quantitative variation of B(a)P 
metabolism which exists between species (15). 
Evaluation of exposure tests require a careful study of 
issues like specificity and sensitivity. Figure 6.7(a)-(d) 
shows that the excretion of 3-OH-B(a)P in urine may be used as 
an indicator of exposure to B(a)P. This suggestion is supported 
by the highly significant correlation found between 3-OH-B(a)P 
concentration and mutagenic activity, despite the certainty that 
3-OH-B(a)P is not the only metabolite that is mutagenic to 
Salmonella typhimurium after biotransformation. 
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The sensitivity of the 3-0H-B(a)P is higher than that of 
the mutagenicity assay. The detection limit of the urinary 
mutagenicity assay is 72 revertant colonies (-mean background in 
urine + 2xSD). This limit corresponds, according to our 
regression eqn (1), with a 3-0H-B(a)P concentration of 436 ng 
per 24-h urine sample. The detection limit of this novel 
3-0H-B(a)P is 1 ng per 24-h urine sample. This means that the 
last assay is about 400 times more sensitive than the urinary 
mutagenicity assay. 
In conclusion, because the concentration of 3-OH-B(a)P in 
urine reflects the degree of exposure to B(a)P the sensitive 
HPLC procedure for the assay of this marker metabolite may have 
promising prospects in the estimation of human exposures. 
Studies of the presence of 3-0H-B(a)P are in progress now. 
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CHAPTER 7 
1-HYDROXYPYRENE IN HUMAN URINE AFTER EXPOSURE TO COAL TAR 
AND A COAL TAR DERIVED PRODUCT 
F.J. JONGENEELEN, R.B.M. ANZION, Ch.-M. LEIJDEKKERS, 
R.P. BOS AND P.Th. HENDERSON. 
Published in: Int. Arch. Occup. Environ. Health 57 (1985) 47-55. 
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ABSTRACT 
A method for isolating 1-hydroxypyrene from urine is described. 
The presence of 1-hydroxypyrene in the urine was identified by 
fluorescence excitation and emission scanning after 
HPLC-separation. 1-Hydroxypyrene could be detected in urine of 
rats following oral administration of as little as 0.5 мд 
pyrene. The dose-dependence of 1-hydroxypyrene in urine was 
evident after a wide range of pyrene dosing. After 
therapeutical coal tar treatment of dermatological patients the 
enhanced excretion of 1-hydroxypyrene was highly significant. 
Employees of a creosote impregnating plant showed an excretion 
pattern of 1-hydroxypyrene which could be related to their work. 
1-Hydroxypyrene in urine of non-exposed people was very low, but 
detectable. It is suggested that the method reported is 
suitable for the assessment of uptake of pyrene, a compound that 
is commonly present in work environments which are associated 
with pollution of polycyclic aromatic hydrocarbons. 
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INTRODUCTION 
Most of the polycyclic aromatic hydrocarbons (PAH) with four or 
more condensed benzene rings are mutagenic or carcinogenic 
(IARC, 1983). Occupational exposure to PAH is caused by two 
fundamentally different sources of PAH: 
I - combustion of petroleum products; and 
II - handling of carbonaceous materials, mostly at elevated 
temperatures. 
Mutagenic and carcinogenic PAH are generally adsorbed on 
particulate matter. Intake of these particles may occur in the 
lungs and the gastro-intestinal tract as a secondary route. 
Percutaneous absorption is also possible. Therefore, a method 
for monitoring human absorption of PAH is desirable. 
A quantitative index of PAH-absorption can help industrial 
hygienists to identify the highly exposed workers and may offer 
a means of assessing the effectiveness of control measures. 
Recently, the determination of mutagenic metabolites in 
urine with the aid of the Ames-assay was proposed to detect 
occupational exposure to mutagenic PAH. Kriebel et al. (1983) 
reported a higher mutagenic activity in urine of non-smoking, 
coke plant workers than in the non-smoking control group. 
Several other studies have failed to detect enhanced excretion 
of mutagens in the urine of workers exposed to PAH (Meiler and 
Dybing 1980; Clonfero et al. 1983; Bos et al. 1984b). 
However, a dose-dependent excretion of mutagens in the urine of 
- 110 -
rats after exposure to benzo(a)pyrene (B(a)P) was shown 
(Jongeneelen et al. 1985). The poor sensitivity of the urinary 
mutagenicity assay to detect exposure to PAH seems to be the 
cause of the negative results in human urine. 
A major metabolite of a representative compound in 
PAH-mixtures (found in body fluids) may be an alternative index 
of systemic absorption of PAH. B(a)P, is often used as a marker 
or tracer of the presence of PAH in food, water and air. B(a)P, 
however, is a minor component of PAH mixtures in work 
atmospheres (Blome 1983) and is transformed in the body to more 
than 20 metabolites (IARC 1983). Another PAH, pyrene, is always 
present in environmental mixtures of PAH (IARC 1983). If pyrene 
is detectable in the environment, it is very likely that other 
PAH are also present. 1-Hydroxypyrene is a major metabolite of 
pyrene found after incubation with human liver microsomes 
(Jongeneelen et al. 1987) and in the urine of pigs (Keimig et 
al. 19Θ3), rats and rabbits (Boyland and Sims, 1964). 
The available data provide no evidence that pyrene itself 
is carcinogenic to experimental animals (IARC 1983). 
It is interesting to investigate whether urinary 
1-hydroxypyrene can be used as a marker of systemic absorption 
of PAH. The present paper reports the excretion of 
1-hydroxypyrene and its conjugates in the urine of rats after 
pyrene administration, of dermatological patients undergoing 
coal tar treatment, of workers at a creosote impregnating plant 
and of non-exposed men. 
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MATERIALS AND METHODS 
Chemicals 
Analytical grade pyrene (purity > 99 %) was obtained from Serva, 
Heidelberg, FRG. 1-Hydroxypyrene was synthesized by Janssen 
Chimica, Belgium. The identity was confirmed with the use of 
GC-MS and NMR. ß-glucuronidase/aryl sulphatase was obtained 
from Boehringer, Mannheim, FGR. All other chemicals were of the 
highest purity obtainable. 
Animals, urine collection and pyrene dosing 
SPF male Wistar rats, weighing about 250 g, were housed 
individually in stainless steel metabolism cages, designed for 
the separate collection of urine and faeces. The rats had free 
access to water and food. 
Five groups of three rats were orally administered 0.05, 0.5, 5, 
50 and 500 μg of pyrene, suspended in 0.25 ml olive-oil per rat. 
Urine samples were collected every 24 h, beginning on the day 
before administration, then the day of administration and over 
the next three days. The samples were frozen until required. 
Dermatológica! patients, treated with a coal tar ointment 
Two female, non-smoking patients (age of patient A was 20 years, 
patient В was 29 years old), both suffering from eczema on the 
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arms and legs, were treated for several days with an ointment 
containing 10% pix lithanthracis dermata (- coal tar). During 
the treatment the ointment was removed daily with arachis oil 
and a fresh dose was applied. A representative dose was weighed 
and turned out to be 40 g. This dose was rubbed daily on the 
arms and legs of both patients. The patients were asked to 
collect urine samples, one before application of the ointment 
and then in the morning and the evening of the first three days 
of treatment. A pre-treatment sample of patient A was not 
available. 
Workers of a creosote impregnating plant 
The creosote, produced by distillation of coal tar, is used to 
preserve wood. The impregnation installation was not enclosed 
in a building and the process is described elsewhere (Bos et al. 
1984b). Three plant-workers, the process operator (person A), 
an employee who transports the treated and untreated wood 
(person B) and the chief operator (person C) were asked to 
collect the overnight urine and the urine voided between 10:00 
and 16:00 h over a period of ten days. Wood was creosoted on 
every workday (Monday-Friday) during the sampling period in 
February 1962. Person A was a smoker, В and С were non-smokers. 
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Non exposed controls 
Sixteen non-exposed men were asked to collect a urine sample. 
The mean age of the seven non-smokers was 29.7 years, and that 
of the nine smokers was 29.9 years. 
Pre-treatment of urine 
Rats. Twenty-four-hour urine samples were diluted to 20 ml. 
Ten ml of the diluted rat urine sample were adjusted to pH 5.0 
with 1.0 N HCl, buffered with 10 ml 0.1 M acetate buffer (pH 
5.0) and incubated overnight with 12.5 μΐ of 
ß-glucuronidase/aryl sulphatase (1250 U) at 37°C in a shaking 
apparatus. A sep-рак C18 cartridge was used for the separation 
of the metabolites of PAH. After priming the cartridge with 5 
ml methanol, followed by 10 ml water (aqua dest), the hydrolyzed 
sample passed the cartridge at a rate of approximately 10 
ml/min. Subsequently the cartridge was washed with 8 ml water. 
Retained solutes were eluted using 10 ml methanol. The solvent 
was evaporated at бО'С under a constant flow of nitrogen and the 
residue dissolved in 2.0 ml methanol. 
Human samples. Twenty-five ml were adjusted to pH 5.0 with 1.0 
N HCl, buffered with 10 ml 0.1 M acetate buffer (pH 5.0) and 
incubated overnight with 25 μΐ ß-glucuronidase/aryl sulphatase 
(2500 U) at 37°C in a shaking apparatus. The metabolites were 
separated as described for the rat urine. 
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The recovery of 1-hydroxypyrene was determined in a spiked 
urine sample (50 uq/l). The yield was 78 + 2% (n-8). The 
coefficient of variation (CV) for eight determinations was 2.6%. 
The urinary creatinine was determined with an automated analyser 
technique based on the reaction of creatinine to the alkaline 
picrate. 
Reversed phase HPLC analysis 
Analyses were performed with a Kipp Analytica HPLC. Using a 
sample loop, an aliquot of 20 μΐ was injected on a 150*4 mm ID 
Lichrosorb RP 18 (5 /ш) column (column temperature was 40oC, 
flow 0.8 ml/min). The following program was commenced: 5 min 
90% solvent A (60% bidest, 40% methanol), a linear gradient to 
solvent 90% В (100% methanol) in 40 min, followed by 10 min 90% 
solvent B. A Perkin Elmer type 3000 fluorescence 
spectrofotometer was used for detection. The following 
fluorescence wavelenghts were used: 
lambda ex lambda em 
pyrene 264 381 
1-OH-pyrene 242 388 
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RESULTS 
Dose-dependent excretion of 1-hydroxypyrene in rat urine 
after oral administation of pyrene 
In order to investigate the dose dependence of excretion of 
1-hydroxypyrene and to determine the lowest detectable exposure 
in rats, different doses of pyrene were adminstered orally. 
U n i t s Ol 
f l u o r e s c e n c e 
λ^η^Β 38Θ nm X e x . 2¿2nrn 
260 290 320 350 360 390 A20 ¿50 
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Fig. 7.1: Fluorescence excitation (figure 7.1a) and emission 
scans (figure 7.1b) of the peak coinciding with the 
1-OH-pyrene reference standard in the HPLC-
chromatogram of: (1) a rat urine sample; (2) a urine 
sample of a patient, undergoing topical coal tar 
treatment, and (3) the reference itself. 
A major peak in the HPLC-chromatograms of the urine concentrates 
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showed fluorescence characteristics which were identical to that 
of the 1-hydroxypyrene reference (figure 7.1). 
The excretion of 1-hydroxypyrene and its conjugates in 
urine sampled over several consecutive days is shown in 
figure 7.2. 
1-OH-Pyrene ( п д / 2 Д h) 
10.000 
1000 
100-
96 
Time (hrs) 
Fig. 7.2: Excretion of l-OH-pyrene in urine of rats after oral 
administration of the indicated doses of pyrene. 
Each point represents the mean value of three rats. 
The SD of the mean value of the 0- to 24-h urine 
samples were 66, 16, 67, 54 and 61% after 0.05, 0.5, 
5, 50 and 500 //g pyrene/rat, respectively. The arrow 
under the figure indicates the time of administration. 
The dashed line is the upper limit of "normal" l-OH-
pyrene excretion. 
The excretion of 1-hydroxypyrene before the administration was 
7.4 + 2.7 ng/24 h (M + SD, n-15). All values lower than the 
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95-percentile (- 12.8 ng/24h) of urine of untreated rats were 
considered not to be increased. According to this condition, 
the excretion of 1-hydroxypyrene was found not to have increased 
after a dose of 50 ng per rat, whereas after a dose of 500 ng of 
pyrene, excretion of 1-hydroxypyrene had increased. 
The dose dependence of excretion of 1-hydroxypyrene in rats 
was evident within a range of very low to high oral exposure to 
pyrene. Pyrene was not detected in urine of pyrene-dosed rats 
(detection limit - 40 ng/24 h). 
Eczema patients and controls 
According to the estimation of the experienced nurse in charge 
40 g ointment were rubbed daily on the arms and legs of both 
patients. HPLC-analysis of pix lithanthracis dermata with 
fluorescence detection revealed a concentration of 16.7 mg 
pyrene per g. As the ointment contained 10% pix lithanthracis, 
a dose of approximately 67 mg pyrene was applied daily to the 
skin. 
HPLC-analyses of the urine samples of the patients revealed 
several peaks. One of them coincided under identical conditions 
with the 1-hydroxypyrene reference standard (figure 7.3). 
Characterization of the urinary metabolite and the reference by 
fluorescence excitation and emission spectra after 
HPLC-separation showed the identity of the metabolite mentioned 
(figure 7.1). Figure 7.4 shows the level of 1-hydroxypyrene and 
its conjugates in several spot urine samples of patients A and 
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В. No pre- t rea tment u r i n e sample of p a t i e n t A was a v a i l a b l e . 
Units of 
fluorescence 
20 30 ДО 
Time (min) 
Fig. 7.3: HPLC-chromatograms of urine of a non-exposed smoking 
control (a), a patient undergoing topical coal tar 
treatment (b) and the 1-OH-pyrene reference (c). 
Wondering whether there is low, but detectable excretion of 
1-hydroxypyrene in non-exposed persons, we also analyzed urine 
samples of non-exposed, healthy men. The HPLC-chromatogram of a 
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representative urine sample of a control smoker is shown in 
figure 7.3. The level of 1-hydroxypyrene in urine samples of 
controls is presented in figure 7.4. 
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Fig. 7.4: 1-OH-pyrene in urine samples of 16 non-exposed 
controls and 2 patients (A and B) undergoing topical 
treatment with a coal tar ointment. 
NS - non-smokers, S = smokers. 
The mean level of 1-hydroxypyrene in urine of controls was 
290 ng/g creatinine, which is above the analytical detection 
limit of 100 ng/g creatinine. The group was divided into 
smokers and non-smokers. The number of controls was too small 
to test the effect of smoking on pyrene metabolite excretion. 
The levels of 1-hydroxypyrene in urine of patient В before 
treatment and controls were of the same magnitude. After 
starting the treatment the excretion of 1-hydroxypyrene 
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increased approximately 200 times. 
Workers of a creosote impregnating plant 
1 - O H - P y r e n e ( / j g / g creat) 
Sa Sun Mo Tu We Th Fri Sa Sun Mo Tu 
T i m e (days) 
Fig. 7.5: 1-OH-pyrene in urine of 3 workers creosotlng wood. The 
dashed line is the mean level of 1-OH-pyrene in urine 
of controls. The shaded areas are the working periods. 
A - operator, в - wood handler, С - chief operator. 
HPLC analysis with fluorescence detection of creosote revealed a 
concentration of 19.θ mg pyrene per g. The quantity of creosote 
handled daily was 2400 kg. 
The time-course in urinary excretion of 1-hydroxypyrene of 
three workers engaged in the preservative treatment of wood with 
creosote is shown in figure 7.5. Although the saving of the 
spot urine samples was incomplete, the excretion pattern of 
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1-hydroxypyrene was drawn. Person В had a day off on Friday. 
As expected, person B, who was most directly involved in the 
handling of wood, excreted the most 1-hydroxypyrene, whereas the 
chief operator С had the lowest excretion values. All values of 
1-hydroxypyrene in urine of the creosote workers were above the 
mean value of the controls. The results demonstrate, at least 
for the workers A and B, an increase during the working week and 
a decrease over the weekend. The small increase in the course 
of the week and decrease over the weekend indicates an 
accumulation of pyrene. 
DISCUSSION 
After oral administration of pyrene to rats, a major metabolite 
found in urine was 1-hydroxypyrene. Excretion of this 
metabolite was dose dependent and was well detectable after a 
dose of 500 ng pyrene. The high SD-values refer to high 
interindividual differences of the metabolism of pyrene. 
In spite of this, this assay offers the possibility of 
estimating exposure to pyrene, even at a very low exposure 
level. 
This report shows excretion of 1-hydroxypyrene in urine of 
controls, who were not exposed. Smoking is a confounding 
factor, but it seems only to be relevant at low exposure levels. 
The bias caused by smoking should be studied in a large control 
group. 
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An estimation of human intake of pyrene is not available. 
However, knowing that the daily intake of B(a)P in the 
Netherlands is estimated between 2-20 pg (Verhoeve and Compaan 
1980) and that pyrene is a more dominant PAH, one can expect a 
higher daily intake of pyrene. Apparently, exposure to pyrene 
as an environmental contaminant is high enough to detect 
excretion with the assay reported. 
Coal tar contains mutagenic and carcinogenic compounds. 
Among those are the PAH (IARC 1983). Cutaneous penetration of 
acridine (Cernikova et al. 1983) and increased excretion of 
mutagens in urine (Wheeler et al. 1981) was shown after 
therapeutic coal tar treatment. This report shows an 
approximately 200-fold increase in excretion of 1-hydroxypyrene 
after the application of a coal tar ointment. The concern that 
other, carcinogenic PAH from coal tar are also absorbed 
percutaneously must be raised. Although the skin of the 
patients was not healthy, we assume that estimation of exposure 
via the skin of healthy people by means of this method is 
possible. 
Creosote is a distillation product of coal tar and it 
contains carcinogenic PAH, such as benzo(a)pyrene and 
benz(a(anthracene (Bos et al. 1984a). In the creosote 
impregnating plant exposure to PAH may occur via the skin and 
the lungs. The concentration of 1-hydroxypyrene in urine of 
three workers was above the level of the controls during the 
sampling period of 10 consecutive days. Two of the workers 
showed a clear increase of excretion which could be related to 
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their work. As pyrene is not the only PAH present in creosote, 
the concern is raised that other, carcinogenic PAH are absorbed 
as well. 
Although creosote contains substantial amounts of mutagens, 
we failed to detect mutagenic metabolites in the same urine 
samples (Bos et al. 1984b). The novel method for monitoring 
exposure to PAH by means of a marker metabolite appears to be 
more sensitive. 
To summarize, the results show that the method reported is 
suitable for the assessment of human uptake of pyrene, a 
component that is commonly present in PAH-containing substances. 
Further studies are needed to elucidate whether pyrene may be 
used as a marker to trace exposure to other mixtures of PAH. As 
yet, we recommend the use of this method of biological 
monitoring to identify highly exposed workers and to detect 
hidden exposure to PAH. 
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ABSTRACT 
JONGENEELEN F J, BOS RP, ANZION RBM, THEUWS JLG and HENDERSON PT. 
Biological monitoring of polycyclic aromatic hydrocarbons: 
Metabolites in urine. Scand J Work Environ Health 12 (19Θ6) 
137-143. Assays of urinary mutagenicity, urinary 
3-hydroxy-benzo(a)pyrene, and urinary 1-hydroxypyrene were used 
to study their suitability in estimating exposure to polycyclic 
aromatic hydrocarbons (PAH) in coal tar products. Rats exposed 
to coal tar solutions applied on the dorsal skin excreted 
mutagens, 3-hydroxy-benzo(a)pyrene, and 1-hydroxypyrene dose 
dependently in their urine. The correlation between the three 
parameters was high. Five dermatologie patients undergoing 
topical coal tar treatment excreted low concentrations of 
3-hydroxy-benzo(a)pyrene and high concentrations of 
1-hydroxypyrene. A significant correlation between the 
excretion of the two metabolites was found. The smoking workers 
of a coal tar distillation plant showed a significantly enhanced 
urinary mutagenicity compared with their non-smoking colleagues, 
but an increase due to occupational exposure was not found. 
However, the concentration of 1-hydroxypyrene in urine of these 
workers highly exceeded the upper 95 percentile of a reference 
population. The urinary excretion of 1-hydroxypyrene of smoking 
referents was not significantly increased compared with that of 
non-smoking referents. The data suggest that urinary 
1-hydroxypyrene is a sensitive and specific marker for the 
assessment of occupational exposure to PAH. 
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INTRODUCTION 
The assessment of exposure in the workplace becomes very 
complicated when workers are exposed to a mixture of compounds 
with similar physical and chemical properties. The polycyclic 
aromatic hydrocarbons (PAH) are an important class of compounds 
occurring in tarry products. They include several carcinogens 
of varying potency (6). The measurement of each component is 
impractical to perform on a routine basis. A pragmatic approach 
to the problem of exposure assessment demands the use of an 
index of the class of compounds, i.e. a marker. 
The organic part of airborne particulates, characterized by 
the benzene-soluble matter (BSM) is an index which is widely 
used in the monitoring of PAH in the work environment (7). 
Lindstedt & Sollenberg (12) reviewed the occurrence of PAH in 
the occupational environment, referring to airborne 
benzo(a(pyrene measurements as a single marker. 
Air monitoring of PAH only quantifies the respiratory 
intake (external dose). PAH may be absorbed not only in the 
lungs, but also in the gastrointestinal tract and through the 
skin (10). The monitoring of PAH or their metabolites in body 
fluids reflects the total uptake (internal dose). Biological 
monitoring of PAH may thus be useful in order to make an 
accurate estimation of the individual dose. It can help 
industrial hygienists to identify highly exposed workers. 
Moreover, unbiased estimations of exposure to PAH are needed to 
increase the power of epidemiologic studies. 
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It is desirable to have a simple noninvasive test which can 
detect industrial exposure to PAH (15). This study reports the 
results of the application of the following three urine tests 
after exposure of man and rat to PAH: 
1. The mutagenicity in urine extracts as an analytical detector 
of exposure (3, 4, 5, 11, 14, 18). 
2. Determination of urinary 3-hydroxy-benzo(a)pyrene, a 
metabolite of benzo(a)pyrene (9). 
3. Urinary 1-hydroxypyrene as a marker of the internal dose of 
PAH (8). 
These methods were compared in reference to sensitivity and 
specificity. 
MATERIALS, SUBJECTS AND METHODS 
Chemicals 
1-Hydroxypyrene was synthesized by Janssen Chimica, Belgium. 
The identity was confirmed with gas chromatography-mass 
spectrometry and nuclear magnetic resonance (NNR). 
3-Hydroxy-benzo(a)pyrene was obtained from the National Cancer 
Institute, Chemical Carcinogen Reference Standard Repository, 
United States. All other chemicals were of the highest purity 
obtainable. 
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Topical application of coal tar on the skin of rats 
Special pathogen-free (SPF) male Histar rats, weighing about 
200 g, were housed individually in stainless steel metabolism 
cages designed for the separate collection of urine and feces. 
The rats had free access to water and food. Four groups of 
three rats were treated with 0.1 ml solution of coal tar in 
xylene containing 0, 2.5, 12.6 and 53.0 mg coal tar, 
respectively. The coal tar contained 23.2 mg of pyrene and 9.5 
mg of benzo(a)pyrene per gram. The coal tar solution was 
administered to approximately nine cm2 of the clipped dorsal 
skin. After 24 h the treated back of the rats was cleaned with 
90/10% olive oil/light petroleum. Twenty-four-hour urine 
samples were collected for 5 days and stored at -IS"С until 
required for analysis. 
Dermatological patients, treated with a coal tar ointment 
Five female patients (patient A, B, C, D and E, mean age 25 
years, range 20-29 years), suffering from eczematous dermatitis 
on the arms and legs, were treated during several days with an 
ointment containing 10% pix lithanthracis dermata ( - coal tar). 
The pix lithanthracis dermata used contained 16.7 mg of pyrene 
and 7.0 mg of benzo(a)pyrene per gram. During the treatment the 
ointment was removed daily with arachis oil, and a fresh dose of 
approximately 40 g of ointment was rubbed on to stay for the 
next 24 h. The patients volunteered to collect spot urine 
samples, one urine sample before the start of the application of 
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the ointment and two samples per day (morning and evening) 
during the first three days of treatment. A pretreatment sample 
from patient A was not available. Patients A and в were 
non-smokers; patients C, D and E were smokers. The urine 
samples were stored at -18°C. 
Workers of a coal tar distillation plant 
The crude coal tar obtained from steel works was fractionally 
distilled in a closed system. The most of the distillate 
fractions were blended to meet product specifications. Products 
from this plant were: carbon black oil, creosote, electrode 
pitch, pitch, roofing material, coatings, fluxing oil (road 
binder), road tars etc. Fourteen male workers from the "tar 
department" were employed in eight different jobs; they were 
foremen, assistent foremen, operators, a mechanic and a cleaner. 
They were supposed to be highly exposed workers. The mean age 
of the 4 non-smokers and 10 smokers was 24.2 (range 19-32) and 
33.9 (range 21-46), respectively. All 10 smokers smoked more 
than 20 cigarettes per day. The personal sampling of PAH was 
performed during eight shifts. The method covered both gaseous 
and particulate PAH (17). Urine samples from the workers were 
collected on the first, the middle, and the last day of a seven 
days work period. The participants were required to void at the 
beginning and end of the work shift. The work period was 
preceded by a workfree period of three days. The urine samples 
were stored at -18'C. 
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Referents 
Hale referents (students and university personnel) were asked to 
collect spot urine samples. Age and smoking habits were 
recorded. The mean age (range) of the 22 smokers was 30.4 
(range 23-54) years; the mean age of the 24 non-smokers was 31.4 
(range 22-47) years. Ten men smoked 0-10 cigarettes, four men 
10-20 cigarettes and seven men smoked more than 20 cigarettes 
per day. One person smoked five cigars per day. 
Analysis of urine samples 
Mutagenicity in human urine. The method for the determination 
of mutagenic metabolites in urine has been described by Yamasaki 
& Ames (22). We modified this method by using a volume of urine 
corresponding to an amount of 1.0 mmol creatinine instead of 
urine concentrates of 100 ml portions. The urinary metabolites 
were concentrated with a column with a 4 cm' bed volume of 
Amberlite XAD-2. The adsorbed material was eluted with 10 ml of 
acetone. The eluate was evaporated to dryness and the residue 
was dissolved in 0.4 ml dimethylsulphoxide (DMSO). This 
solution (0.1 ml) was added per plate and assayed in triplicate 
for mutagenicity with the Salmonella typhimurium tester strain 
ΤΑ9Θ in the presence of S-9 mix and ß-glucuronidase (150 U per 
plate). The solvent value was obtained with the use of 100 ml 
of aqua destilata (aqua desty, ie, distilled water) instead of 
urine. The human urinary mutagenicity values were expressed as 
follows: 
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Rj, mean number of revertants found with urine 
% mean number of revertants found with aqua dest 
Mutagenicity in rat urine. A complete discription of the 
mutagenicity assay of rat urine has been given elsewhere (9). 
The 24-h urine samples from the groups of three rats undergoing 
topical coal tar treatment were pooled. Two-thirds of the 
pooled 24-h samples were concentrated on a XAD-2 column. The 10 
ml acetone eluate was evaporated, and the residue dissolved in 
0.7 ml DMSO. The amount of 0.1 ml per plate was assayed in 
triplicate for mutagenicity with the Salmonella typhimurium ΤΑ9Θ 
strain in the presence of S-9 mix and ß-glucuronidase (150 U per 
plate). The mutagenicity of the rat urine was expressed in 
revertants per plate. 
Urinary metabolites of polycyclic aromatic hydrocarbons 
The analytical method for the determination of 
3-hydroxy-benzo(a)pyrene and 1-hydroxypyrene has been described 
elsewhere (Θ, 9 ). The analysis is based on enzymic hydrolysis, 
followed by a concentration step, and the determination of the 
metabolite with a high-pressure liquid Chromatograph (HPLC) 
equipped with a fluorescence spectrofotometer. The identity of 
the two PAH metabolites was confirmed in the mobile phase after 
HPLC separation through comparison of the fluorescence 
excitation and emission scans of the metabolites with that of 
the references. The detection limit (signal/noise > 4) for 
urinary 3-hydroxy-benzo(a)pyrene and 1-hydroxypyrene is 0.5 
nmol/1 for both metabolites. 
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The urinary creatinine was determined with an automated 
technique based on the reaction of creatinine to the alkaline 
picrate. 
Statistical methods 
Statistical significance of the differences was tested with the 
non-parametric Mann-Whitney U test. Correlation was qualified 
with Spearman's rank correlation coefficient (rg). p-Values 
refer to two-tailed tests. Data were presented with either the 
arithmetic mean (AM) or the geometric mean (GM), the latter 
being more representative of a highly skewed distribution of 
data. 
RESULTS 
Rats undergoing topical application of coal tar 
The pooled rat urine samples were assayed for mutagenicity, 
3-hydroxy-benzo(a)pyrene and 1-hydroxypyrene. Table 8.1 shows 
the results of the analyses. With each of the three methods we 
were able to detect a dose-dependent uptake through the skin. 
It is obvious that the excretion of 1-hydroxypyrene was highly 
enhanced even after low exposure levels. The association 
between the concentration of 1-hydroxypyrene and that of 
3-hydroxy-benzo(a)pyrene was studied in urine samples from five 
postexposure days. The correlation was high, although the 
number of samples in which both metabolites were detected was 
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limited (rs - 0.94, N « 9, ρ < 0.005). Regression analysis 
TABLE 8.1. Urinary excretion of mutagenic metabolites, 
3-hydroxybenzo(a)pyrene, and 1-hydroxypyrene after 
topical treatment of rats with solutions of coal 
tar in xylene.' 
[ND - not detectable (< 0.01 nmol/24 h)J. 
Applied coal 
tar 
0- to 24-h excretion 
0 mg/rat 
2.5 mg/rat 
12.6 mg/rat 
53.0 mg/rat 
24- to 48-h 
0 mg/rat 
2.5 mg/rat 
12.6 mg/rat 
53.0 mg/rat 
48- to 72-h 
0 mg/rat 
2.5 mg/rat 
12.6 mg/rat 
53.0 mg/rat 
72- to 96-h 
0 mg/rat 
2.5 mg/rat 
12.6 mg/rat 
53.0 mg/rat 
96- to 120-h 
0 mg/rat 
2.5 mg/rat 
12.6 mg/rat 
53.0 mg/rat 
excretion 
excretion 
excretion 
excretion 
Mutagenic 
metabolites 
(revertants/ 
plate) 
47 
90 
135 
146 
49 
66 
101 
141 
44 
44 
74 
109 
44 
44 
52 
69 
44 
48 
55 
52 
3-hydroxy-
benzo(a)-
pyrene 
(nmol) 
ND 
0.03 
1.72 
2.99 
ND 
ND 
0.54 
5.44 
ND 
ND 
0.04 
1.21 
ND 
ND 
ND 
0.31 
ND 
ND 
ND 
0.04 
1-hydroxy­
pyrene 
(nmol) 
0.14 
7.75 
26.3 
73.3 
0.60 
3.57 
17.2 
99.9 
1.15 
1.6Θ 
7.28 
23.7 
0.22 
0.98 
2.46 
12.75 
0.37 
0.55 
1.45 
4.88 
') Mean of three rats. 
showed a linear relationship [slope 5.3 χ 10-2, 95% confidence 
limits (95% CL) 4.4 χ 10-2 and 6.2 χ 10-2, intercept -0.26, 
r » 0.98, N • 9J. The excretion of 1-hydroxypyrene was 
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positively associated with and approximately 19 times higher 
than that of 3-hydroxy-benzo(a)pyrene. 
60 80 100 
1-OH-pyrene (>jmol/2¿h) 
Fig. 8.1. Correlation between 1-hydroxypyrene (X) and 
mutagenicity (Y) in 24-h urine samples from rats 
after topical application of coal tar solutions. 
Each point represents the mean of three rats 
(N - 12, rp - 0.93, ρ < 0.001, 
Ϊ - 30 + 25.1 χ Inx). 
Figure Θ.1 shows the mutagenicity of the urine samples as a 
function of the amount of 1-hydroxypyrene in 24-h urine samples. 
Only those urine samples with higher mutagenicity values than 
the upper 95 percentile of the reference urine ( - 50.2 
revertants/plate) were taken into account. An association 
between 1-hydroxypyrene and mutagenic metabolites (rg - 0.93, 
N - 12, ρ < 0.001) was found. Regression analysis showed a 
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logarithmic correlation as the best fit 
[mutagenicity - a + b χ In(l-hydroxypyrene), slope 25.1, 95% CL 
17.9 and 32.3, intercept 30, r - 0.93]. 
Eczema patients 
The mutagenicity of the urine samples of the five patients with 
eczema could not be assayed because of the toxic properties of 
the urine extracts to the S typhimuгium bacteria, even after 
dilution of the extracts. 
l-OH-pyrenetjumol/mol creat) 
Time (days) 
Fig. 8.2. Semilogarithmic plot of the urinary excretion of 
1-hydroxypyrene for five patients undergoing topical 
coal tar treatment. The arrow indicates the start of 
the application, (creat - creatinine) 
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The excretion pattern of 1-hydroxypyrene in urine is given 
in figure 8.2. After the treatment was started, the 
concentration of 1-hydroxypyrene increased approximately 100 
times. The enhanced level of the "pre-treatment" samples of the 
patients C, D and E compared with the values of the referents 
might have been caused by an unknown treatment from days before. 
3-Hydroxy-benzo(a)pyrene was detected in the urine samples, 
but the concentrations were not higher than 0.40 ¿/mol/mol 
3-OH-B[a]P(>jmol/mol créât) 
0.4 -ι 
0.3 -
0.2-
0.1-
o 
о 
100 200 300 400 500 
1-OH-pyrenel^imol/mol créât) 
Fig. 8.3. Correlation between 1-hydroxypyrene (X) and 3-hydroxy-
benzo(a)pyrene (Y) in spot urine samples of patients 
undergoing topical coal tar treatment (N - 13, 
r s - 0.86, ρ < 0.01, Y - 0.020 + 4.0 χ 10-4 χ Χ). 
(créât » creatinine) 
creatinine. Figure 8.3 shows the fitted linear regression line 
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in a plot of the 1-hydroxypyrene concentration and that of 
3-hydroxy-benzo(a)pyrene from the posttreatment urine samples 
[slope 4.0 χ 10-4, 95% CL 1.3 χ 10-4 and 6.7 χ 10-4, intercept 
0.020, N - 13]. The level of the pyrene metabolite was about 
2500 times higher than that of the benzo(a)pyrene-metabolite 
(figure 8.3). A significant association was found between the 
urinary level of 1-hydroxypyrene and 3-hydroxy-benzo(a)pyrene 
(r s - 0.86, ρ < 0.01, Ν - 13). 
Workers in a coal tar distillation plant 
The urine samples of the 14 men from the coal tar destination 
plant were tested for mutagenicity (N - 69). The smoking 
workers revealed significantly more mutagenic compounds and/or 
metabolites in their urine than did their non smoking colleagues 
R Φ [ ft q- (AM) - 4.8 and 1.8 and the 95% confidence interval (95% 
CI)1.0-8.6 and 1.0-2.6, respectively, Mann-Whitney U test, 
ρ < 0.0001]. No enhancement of urinary mutagenicity was 
observed, either in the course of the shift, or in the course of 
the work period of seven days. 
The concentration of 3-hydroxy-benzo(a)pyrene in the urine 
of the workers was below the detection limit. 
Only 10 urine samples from these workers were available for 
the determination of 1-hydroxypyrene. These urine samples were 
from four workers, namely, 1) the operator of the pitch unit, 2) 
the operator of the batch distillation, 3) the operator of the 
pumping station and 4) the cleaner. Seven samples were 
collected before and three after the shift. The time-weighted 
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average (TWA) exposure over 8 h for these four workers was 
<2-280 pq/m' for the sum of eleven PAH and <2-96 iug/m3 for 
pyrene (17). The mean (GM) concentration of 1-hydroxypyrene in 
the urine from the four workers and 46 referents is shown in 
table 8.II. 
Table 8.II. Exposure of employees in a coal tar distillating 
plant to polycyclic aromatic hydrocarbons (PAH). 
Function 
Personal sampling' 
Biological monitoring 
of 1-hydroxypyrene 
(i/mol/mol creatinine) 
Number Total PAH Pyrene 
of 
samples (//g/m') (/yg/rn·) 
Number Geo-
of metric 
samples mean 
Operator, ) 8 
pitch unit} 
Operator, } 
batch } б 
distillation} 
Operator, } 
pumping } 5 
station } 
26 
14 
Cleaner 
Referents 
4 
46 
4.7 
16 
8.5 
5.1 
1.4 
5.2 4 
46 
3.7 (non-
smoker) 
11.8 (smoker) 
4.0 (non-
smoke r) 
4.6 (smoker) 
0.25 (non-
smokers 
+ 
smokers) 
1) Geometric mean of the time-weighed average exposure over 8 h 
as measured by Nossent & van de Ven (17). 
The enhanced level of 1-hydroxypyrene in workers urine compared 
with the referents is obvious. Table 8.II also shows the 
results of the personal monitoring of the four workers. The sum 
of the concentrations of eleven PAH, including pyrene, and the 
concentration of pyrene is presented. It demonstrates that 
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pyrene was a major compound of the PAH mixture in this work 
environment. 
Referents 
The concentration of urinary 3-hydroxy-benzo(a)pyrene was below 
the detection limit in the referents' urine. 1-Hydroxypyrene 
was identified in all the samples. The distribution of urinary 
1-hydroxypyrene in the reference population appeared to be 
positively skewed. To make the data appropriate for analysis, a 
logarithmic transformation was applied. The samples revealed a 
mean (GM) concentration of 1-hydroxypyrene of 0.25 pmol/mol 
creatinine (95% CI 0.06-1.00). The concentration of 
1-hydroxypyrene in the urine of the smokers (GM 0.27, 95% CI 
0.06-1.15) was not significantly increased compared with that of 
non-smokers (GM 0.23, 95% CI 0.05-0.85, Mann-Whitney U test, 
ρ - 0.27). 
DISCUSSION 
Recently, a new procedure for the estimation of exposure to PAH 
has been proposed (2). The procedure involves HPLC analysis 
after chemical reduction of the urinary PAH metabolites to their 
parent PAH. As yet, the proposed chemical reduction procedure 
has not been validated with urine samples spiked with PAH 
metabolites. Therefore, we did not include this assay in the 
comparison of the methods. 
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The exposure of rats to topically applied coal tar can be 
assessed with the urinary mutagenicity assay (table Θ.Ι). The 
mutagenicity of the urine samples of rats was found to correlate 
with the (logarithm of the) concentrations of 
3-hydroxy-benzo(a)pyrene and that of 1-hydroxypyrene. A similar 
relationship was found after oral administration of 
benzo(a)pyrene to rats (9). Two volunteers excreted mutagenic 
urine after a single application of 5% crude coal tar in 
petrolatum to the trunk skin (the dose was not given) (21). 
Nevertheless, we did not detect an elevated level of 
mutagenicity in the urine of FAH-exposed workers, either in this 
study or in another (3). The applicability of this assay after 
occupational exposure to PAH seems to be limited. This 
conclusion is supported by work of other investigators, who 
failed to detect an enhanced excretion of mutagens in urine of 
workers exposed to PAH (4, 14, 16). However, Kriebel et al. 
(11) reported a higher mutagenic activity in urine of 
non-smoking coke plant workers than in that of non-smoking 
referents. Among non-smoking employees of an aluminum plant, a 
slight but significantly higher percentage of workers exposed to 
coal tar pitch volatiles showed higher urinary mutagenicity than 
non-exposed workers (5). The evaluation of these conflicting 
data is difficult, because the mentioned studies did not report 
on simultaneous ambient monitoring, except the study of Clonfero 
et al. (4) and the present report. It seems that the excretion 
of urinary mutagenic PAH metabolites after occupational PAH 
exposure is too low to detect the presence of these compounds in 
urine. Moreover, smoking is a major determinant in urinary 
- 143 -
mutagen activity, and this factor makes the assay less suitable 
for monitoring occupational exposure to PAH. 
3-Hydroxy-benzo(a)pyrene was detected in human urine after 
the application of high (therapeutical) doses of a 10% coal tar 
ointment. After topical treatment of rats with an equal 
(corrected for body weight) dose of coal tar, the urinary 
excretion of this benzo(a)pyrene metabolite was much higher than 
that of the patients. The benzo(a)pyrene-hydroxylating activity 
of human liver in vitro has been found to be much lower than 
that of rodent liver (16, 19). In spite of a high analytical 
sensitivity, 3-hydroxy-benzo(a)pyrene was not detectable in 
human urine after occupational exposure to coal tar products. 
For biomonitoring of occupational exposure, the determination of 
urinary 3-hydroxy-benzo(a)pyrene therefore seems to be less 
suitable. 
Fyrene is a predominant compound in environmental PAH 
exposure (6). The urinary excretion of 1-hydroxypyrene of 
dermatologie patients was highly enhanced after application of a 
coal tar ointment. Three workers of a creosote impregnation 
plant showed enhanced levels of 1-hydroxypyrene in urine over a 
period of ten days (8). Even after a TWA exposure to PAH of 
< 2-280 iig/m' in the work environment of the coal tar 
distillation plant, the urinary 1-hydroxypyrene concentration 
highly exceeded the upper 95 percentile of the referents. These 
examples illustrate the high sensitivity of the test. 
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Mainstream smoke of cigarettes contains 5-27 pq of pyrene 
per 100 cigarettes (6). Smoking 10 cigarettes a day results in 
a pyrene intake of 0.5-2.5 /yg/day. On the assumption that only 
a minor part of the pyrene metabolites, like benzo(a)pyrene 
metabolites (13, 20) will be excreted in urine, it is made 
plausible that the maximum elevation of urinary 1-hydroxypyrene 
due to smoking is 0.2-1.1 nmol/day. Since the excretion of 
creatinine in the urine of males is 16 inmol/24 h (1), the 
increase caused by smoking 10 cigarettes daily is estimated to 
be 0.01-0.07 ^mol/mol creatinine. This estimated enhancement is 
in accordance with the measured difference between smoking and 
non-smoking referents. Smoking habits appear to be a minor 
confounder when exposure is assessed through the determination 
of the concentration of 1-hydroxypyrene in urine. 
A significant correlation between the urinary 
1-hydroxypyrene and the urinary 3-hydroxy-benzo(a)pyrene was 
found after exposure of patients and rats. Apparently, the 
kinetics of pyrene elimination from the body is comparable with 
that of benzo(a)pyrene. A significant correlation between 
1-hydroxypyrene and mutagenicity was also shown in urine of rats 
treated with coal tar. It is very likely that most of the 
mutagenicity on strain TA98, a strain very sensitive for 
frameshift mutagens, originates from the PAH in coal tar. 
Therefore, the occurrence of elevated levels of 1-hydroxypyrene 
in urine not only signals exposure to pyrene but most probably 
also to other PAH. Since exposure to pyrene always occurs in 
PAH mixtures, the 1-hydroxypyrene assay is not only suitable for 
the assessment of exposure to pyrene, but it might also be used 
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as a marker for the assessment of exposure to PAH. However, the 
representativeness of 1-hydroxypyrene in respect to the 
biological potency has to be studied and verified for different 
PAH exposures. 
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ABSTRACT 
The exposure of workers in three different environments to 
polycyclic aromatic hydrocarbons (PAH) was assessed by the 
determination of a marker-metabolite in urine. Preliminary 
results of a study among asphalt road paving workers showed 
increased levels of urinary 1-hydroxypyrene when tar blended 
asphalt or tar blended asphalt-mix is applied. The high level 
of 1-hydroxypyrene in urine of an operator of a creosote 
impregnation installation suggested substantial exposure to 
creosote volatiles, including PAH. No significant increase in 
the 1-hydroxypyrene level in urine of workers exposed to exhaust 
gases of diesel engines was found. It was not clear whether 
this was caused by a low pyrene concentration in diesel exhaust 
gas or by a low airborne diesel exhaust concentration. 
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INTRODUCTION 
Recently, a method for the determination of hydroxylated 
polycyclic aromatic hydrocarbons (PAH) in urine has been 
proposed (1). Especially 1-hydroxypyrene has been suggested as 
a biological indicator of exposure to PAH (2). This report 
presents the results of the analyses of urine samples of people, 
working in three different environments which were thought to be 
contaminated with PAH. 
ASPHALT ROAD PAVING 
Hot petroleum derived bitumens and blends of refined coal tar 
with bitumen are employed for the construction and maintenance 
of roads, either as a component in mixes with crushed and sized 
mineral aggregates, or as thin films to seal surfaces. A series 
of studies of workers in asphalt road paving show that the 
concentration of PAH is moderate when petroleum bitumens are 
applied (3, 4, 5). The exposure to PAH is higher when blends of 
bitumen and refined coal tar are applied, although measuring 
data are scarce (6,7). In the Netherlands, ca 5% of the binder 
in road paving contains refined coal tar, mainly in binders for 
surface dressing (8). 
A survey of the exposure to PAH of ashalt road paving 
workers was performed at 10 different paving sites. 31 Road 
paving workers who were active in surface dressing operations or 
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hot asphalt mix laying volunteered in this study. The workers 
were asked to sample urine just before and direct after work 
(pre- and postwork urine). In total, 61 prework and 5Θ postwork 
urine samples were collected. The preliminary results of the 
biological monitoring are shown in table 9.1. By each paving 
site, the mean 1-hydroxypyrene level of the pre- and postwork 
urine samples is presented. Table 9.1 shows an increase of 
1-hydroxypyrene in urine over the day. The mean prework and 
postwork 1-hydroxypyrene levels were over the upper 
95-percentile of 1-hydroxypyrene in urine of a smoking control 
group [- 1.15 /лпоі/mol creat (2)), except for the workers at the 
sites D and H. At the paving site H petroleum based asphalt was 
handled. At the 9 other sites, blends of bitumen with refined 
coal tar were applied. 
Table 9.1. 1-Hydroxypyrene in urine of road paving workers 
Paving number number prework postwork 
site of measuring of workers urine urine 
days per site sample' sample* 
С 1 
D 1 
E 1 
F 3 
G 2 
H 1 
I 1 
К 1 
2 
4 
2 
3 
3 
3 
3 
2 
1.5 
1.1 
3 .1 
1.4 
1.5 
0 .5 
2 . 1 
0.8 
2 . θ 
0.9 
3 . 2 
2 . 2 
3 . 1 
0.6 
2 . θ 
1.2 
1
 Mean //mol/mol creatinine 
The results of the monitoring data of site A will be presented 
in detail. At site A the road workers were involved in surface 
dressing operations. A hot blend of bitumen and refined tar 
- 152 -
(ca. 140 "С) was sprayed onto an existing road surface and was 
covered by an excess of stone chips (» chip sealing). The 
spraying vehicle was closely followed by a chipper vehicle. The 
exposure of the driver/operator of the spraying vehicle was not 
measured, only the three workers of the chipper vehicle (chipper 
disperser and two rakermen) were monitored. Figure 9.1 shows 
the time-course of the 1-hydroxypyrene level in urine of the 3 
workers. 
l-Hydroiypyrene — 
( pmol/mol creatinine) 
_ 1 ι I 
Tuesday Wednesday Thursday 
Time 
Figure 9.1 l-Hydroxypyrene in urine of 3 workers involved in 
road surface dressing operations with a blend of bitumen and 
refined tar. 
On the Monday before the work at site A, the three workers 
involved were not active in paving operations. At the start of 
pavement on site A the 1-hydroxypyrene levels were normal, but 
increased in the course of the next 2 days and exceeded highly 
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the upper limit of the background 1-hydroxypyrene level. These 
preliminary results show the suitability of the new method of 
biological monitoring in detecting exposure to PAH when 
tar-blended asphalt or tar blended asphalt mix is applied. 
EXPOSURE IN A WOOD PRESERVING FACILITY 
Creosote is a wood preservative derived from coal tar. Creosote 
has mutagenic properties and it contains PAH (9). 
At a small wood preserving plant, one operator was active 
in the pressure/vacuum treating process with creosote. The 
installation was placed in the open air. Creosote volatiles 
were emitted from the vacuum-pump exhaust and from the exhaust 
of the creosote dehydratation installation. Creosote volatiles 
were also released during and after the unloading of the charge 
of wood from the cylinder. Possibilities for skin contact were 
considerable. 
During one week -from Tuesday to Monday- the treating 
operator collected pre- and postwork urine samples. The first 
four days and the last day of the sampling period were working 
days. From Tuesday to Friday four charges of wood were 
creosoted daily. On the next Monday five charges were 
creosoted. Figure 9.2. shows the 1-hydroxypyrene level in 
urine during this period. The level is very high, the 
accumulation during the working period is obvious and the 
decrease in the weekend is clear. 
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1-Hydi 
100-1 
Южуругепе 
I/mol creatinine) 
Tu We Th Fri Sa Sun Mo 
Figure 9.2 1-Hydroxypyrene in urine of the operator of a 
creosote impregnation installation. The shaded periods are the 
working hours. 
HPLC-analysis of the creosote used at this plant showed the 
presence of three selected PAH : Pyrene 3.3%, benzo(a)pyrene 
0.01% and benz(a)anthracene 0.3%. Although the PAH-profile of 
creosote volatiles was not known, the exposure of the operator 
to PAH was supposed to be high. It was even 4 times higher than 
at another wood preserving plant (10). Measures are taken to 
control the exposure. 
80 -
60 -
to 
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EXPOSURE TO DIESEL EXHAUST GAS 
Particulate extracts from diesel engine exhaust have been shown 
to contain carcinogenic PAH and have been shown to be cytotoxic 
and mutagenic in several short term in vitro assay systems (11, 
12, 13). The PAH are supposed to be partly responsible for 
these properties. 
Gate-keepers of a large harbour terminal for containers 
were daily exposed to exhaust gases from ca 200 waiting and 
accelerating trucks. Four smoking and three non-smoking 
gate-keepers collected a pre-work urine sample after a period of 
two days off. They were asked to collect samples directly after 
work (post-work), one in the middle of the working week and one 
at the end of the working week. 
Table 9.II 1-Hydroxypyrene in urine from gate-keepers 
exposed to diesel engine exhaust and in urine from 
non-exposed referents 
Smoking Non-smoking 
gate-keepers gate-keepers 
number of 
workers 4 3 
prework sample1 0.42 (0.19) 0.26 (0.08) 
postwork sample1 0.67 (0.24) 0.47 (0.21) 
referents2 0.27 (0.06-1.15) 0.25 (0.06-1.00) 
1
 Mean (SD) /ymol/mol creatinine 
2
 Mean (95% confidence limits) ^mol/mol creatinine (2) 
Table 9.II shows the 1-hydroxypyrene level in these urine 
samples. The mean level of the post work samples was higher 
than the prework samples, both for smoking and non-smoking 
workers. However, the maximum levels were below the upper 
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95-percentile of a group of non-exposed referents [· 1.15 
/«mol/mol creat (2)]. 
In conclusion, the 1-hydroxypyrene level was not 
significantly increased after exposure to diesel engine exhaust 
gases. The results did not clarify whether this was caused by a 
low pyrene concentration in diesel exhaust gas or by a low 
airborne diesel exhaust concentration at the gate of the 
terminal. 
CONCLUSION 
The presence of PAH in refined coal tar products is substantial. 
The results show that the 1-hydroxypyrene in urine test can 
detect industrial exposure to PAH released from these products. 
Other reports show similar results, when workers are exposed to 
refined coal tar products (2, 10). 
When the 1-hydroxypyrene level in urine is elevated, it is 
important to know the PAH-profile of the source and the 
PAH-profile of airborne particulates. These data are necessary 
for the assessment of exposure to the PAH. 
More research is necessary to find out whether the 
1-hydroxypyrene test may be used for biological monitoring of 
PAH from other sources than coal tar like diesel engines. 
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CHAPTER 10 
GENERAL DISCUSSION AND CONCLUDING REMARKS 
The main topics concerning the development and validation of the 
biological monitoring method has been discussed in the preceding 
chapters. Two features need some more attention: (1) the 
concept of a metabolite of one PAH as a biological indicator and 
(2) the application of the suggested method of biological 
monitoring in the preventive industrial health care. 
10.1 THE CONCEPT OF A METABOLITE OF ONE PAH 
In industrial health care, there is a need of a method for 
biological monitoring for the purpose of accurate assessment of 
PAH-exposure of numerous workprs (NIOSH 1977). 
The approach which has been followed in the course of this 
investigation and has been reported in this disseration was 
pragmatic and was inspired by the question whether it is 
possible to estimate the endogeneous exposure to PAH on the 
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basis of measurements of a single metabolite that may serve as a 
representative of the total group of PAH. This approach is a 
simplification of reality, because the PAH-contamination of work 
environments do not show equal PAH-profiles. Different 
workplaces show different PAH-profiles (see Chapter 1). In this 
thesis, the research was directed to find a metabolite, which 
can be representative for the exposure to genotoxic PAH from 
coal tar and coal tar derived products. 
To validate the concept of a marker metabolite and to make this 
approach acceptable, we performed in vitro studies with 
S9-preparations of human and rat liver and in vivo studies with 
crude coal tar according to figure 9.1. 
in vitro | in vitro) 
> | ι 
rat | man | 
I 
I I 
V V 
I in vivo | in vivo 
| ι > 
I rat | man 
Fig. 9.1. Scheme of the performed studies. 
In the studies with the two encircled testsystems of figure 9.1, 
we tested the representativeness of the formation of 
1-hydroxypyrene for the bioactivation of tar compounds. After 
incubation of coal tar with s9-mix of human liver, we found a 
good correlation between mutagenic activation and pyrene 
hydroxylase activity. Also in urine of rats exposed to coal tar 
a highly significant relationship was found between urinary 
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mutagenicity and 1-hydroxypyrene concentration. It seems to be 
valid that the metabolic conversion of pyrene to 1-hydroxypyrene 
reflects the bioactivation of pre-mutagenic compounds in coal 
tar. 
The exposure of workers may be assessed by the level of 
1-hydroxypyrene in urine, when the PAH-profile of the source and 
the profile of the airborne PAH is known. More research is 
necessary to find out whether the 1-hydroxypyrene test may be 
used for biological monitoring of PAH from other sources than 
coal tar products. 
10.2 APPLICATION OF THE SUGGESTED METHOD OF BIOLOGICAL 
MONITORING IN THE PREVENTIVE INDUSTRIAL HEALTH CARE. 
When the basic toxicological investigations have suggested a 
useful biological parameter other demands must be met before 
this test may be applied in preventive industrial health care. 
The demands of a valid biological parameter are (Lauwerys, 
1982): 
- sufficiently sensitive 
- sufficiently specific 
- sufficiently stable to allow storage 
- non-time consuming analysis by a not overly sophisticated 
technique 
- a normal value among non-exposed referents must be 
determined. 
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The sensitivity of the 1-hydroxypyrene determination in 
urine is extremely high; 0.5 nmol/1 (- 0.1 ¿ig/l ). This high 
sensitivity allowed even the determination of trace levels of 
1-hydroxypyrene in a reference population. 
nonsmoking referents 
n- 52 
smoking referents 
nr 38 
04 06 ΟΘ 1 0 12 14 
urinary 1-hydroMypyrene íumol /mol creatinine) 
Fig. 9.2. Frequency distribution of 1-hydroxypyrene in 
reference population. The median, the 
5-percentile (P5) and the 95-percentile (P95) 
are indicated for smokers and non-smokers. 
The selectivity is high; the only known parent compound of 
1-hydroxypyrene is pyrene. HPLC-separation and fluorometric 
detection results in a base-line separation of 1-hydroxypyrene. 
A trace amount of 1-hydroxypyrene in urine was found in 
referents' urine. Figure 9.2 shows the frequency distribution 
of 1-hydroxypyrene in urine in a smoking and a non-smoking, 
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male, non-exposed reference population (n- 38 and 52, 
respectively). Geometric mean (GM), the 5- (P5) and 
95-percentile (P95) are presented of both groups. The 
1-hydroxypyrene in urine of smoking referents was not 
significantly increased compared to the non-smoking referents 
(median - 0.28 versus 0.26 nmol/mmol creatinine). These data 
show that smoking habits is only a minor determinant of 
1-hydroxypyrene in urine. 
The sample stability during long-term storage was tested; 
the samples can be stored in the freezer for at least a year 
without losses (chapter 4). 
The determination is rapid and non-laborious. One trained 
laboratory worker can easily handle 20 urine samples/day. The 
capacity of the HPLC instrumentation is 24 samples/day, when an 
automated injection technique is applied. 
Our prospects of the presented biological monitoring method 
of PAH are high. At the moment, several laboratories of 
occupational health services and international research groups 
are applying the test in field studies. 
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SUMMARY 
This report contains an overview of occupational exposure to PAH 
in several work environments. A summary of epidemiological 
studies about cancer in workers exposed to PAH is presented. 
The discussion of methods in environmental monitoring and the 
lack of validated biological parameters of exposure indicated 
that there is a need of a biological exposure test for PAH. The 
development of such a test on the basis of the measurement of 
PAH-metabolites in urine was the main purpose of the present 
study. 
Human metabolism of PAH was investigated in vitro. The 
metabolism of benzo(a)pyrene and pyrene was studied with 
S9-preparations from human liver samples of 15 kidney transplant 
donors. In these liver preparations, 1-hydroxypyrene was the 
major metabolite of pyrene and 3-hydroxy-benzo(a)pyrene was the 
major metabolite of benzo(a)pyrene. Substantial interindividual 
differences in the apparent hydroxylase isoenzyme constants were 
found. 
Furthermore, the capacity to bio-activate the PAH in crude coal 
tar was studied with S9-preparations from liver samples of five 
donors. The outcome of metabolism was assessed by measurement 
of mutagenicity in the Salmonella/microsome assay and by 
determination of hydroxylated pyrene. A good correlation 
between the mutagenicity and pyrene hydroxylase activity was 
observed. 
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The measurement of two hydroxylated PAH in urine 
- 1-hydroxypyrene and 3-hydroxy-benzo(a)pyrene - was supposed to 
be a useful starting-point for the development of a method for 
biological monitoring of PAH. A high performance liquid 
chromatographic (HPLC) method with metabolite specific 
fluorescence detection was developed. Preceding enzymic 
hydrolysis of conjugated metabolites appeared necessary and a 
solid phase extraction technique and sample clean up was 
applied. The method allowed the determination of the sum of 
free and conjugated metabolites at the nmol/1 level. 
Toxicokinetic characteristics of benzol a)pyrene and pyrene 
were studied in experimental animals after oral ingestion and 
percutaneous penetration. The excretion in urine of 
3-hydroxy-benzo(a)pyrene was faster after oral administration of 
benzo(a)pyrene than when applied an equivalent amount on the 
dorsal skin. The urinary excretion of 3-hydroxy-benzo(a)pyrene 
appeared to be greater after percutaneos penetration than when 
given orally in equal amounts. 
The excretion of mutagenicity and 3-hydroxy-benzo(a)pyrene in 
rat urine were compared after the oral administration of 
benzo(aIpyrene. The mutagenic activities of the concentrated 
urine samples were assayed in the Salmonella/microsome assay. 
The urinary concentration of 3-hydroxy-benzo(a)pyrene and 
mutagenic activity showed a good correlation and both parameters 
appeared to be dose-dependent. 
Crude coal tar was applied on the dorsal skin of rats. A 
dose-response relationship of the three biological parameters 
namely urinary mutagenicity, urinary 1-hydroxypyrene and urinary 
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3-hydroxy-benzo(a)pyrene was found. The correlation between the 
three parameters was high. 
Both the in vitro experiments with hepatic preparations of 
human origin and the in vivo studies with experimental animals 
showed that 1-hydroxypyrene in urine could be a good biological 
parameter of human exposure to PAH from tarry products. The 
first human urine samples which were analysed for 
PAH-metabolitee were from five dermatological patients, treated 
with a coal tar ointment. 1-Hydroxypyrene and 3-hydroxy-
benzo(a)pyrene were identified in these samples. The 1-hydroxy-
pyrene in urine level increased over about 100 times after the 
start of the treatment. in contrast, the 3-hydroxy-
benzo(a)pyrene in urine level was far lower. 
The 1-hydroxypyrene in urine of several groups of workers 
exposed to coal tar pitch volatiles was studied. A source of 
occupational exposure to coal tar PAH is during the use of 
creosote as a wood preservative. Creosote is derived from coal 
tar by batch distillation. Three workers of a creosote 
impregnating plant for wood preservation showed a highly 
increased level of 1-hydroxypyrene in urine. The time course in 
the urinary excretion during a sampling period of 10 days, 
indicated an accumulation during the working week. The 
excretion pattern of 1-hydroxypyrene could be related to the 
work. A second study of the endogenous exposure to creosote of 
a worker from another plant showed even a higher level of 
1-hydroxypyrene in urine. 
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Fourteen workers of a coal tar distillating plant, exposed 
to 2-280 //g/m1 total PAH, volunteered to collect their urine 
during several days. The urine samples were tested for 
mutagenicity and for l-hydroxypyrene. No increase of urinary 
mutagenicity due to work was found, either in the course of the 
shift, or in the course of the working period of seven days. 
However, the level of l-hydroxypyrene in urine of these workers 
highly exceeded the upper 95-percentile of a control population 
of non-exposed referents (n-90). 
A study of the exposure of road paving workers to PAH was 
performed at 10 paving sites where roads were sealed either by 
hot aspalt mix laying or by chip sealing. The study was focused 
to the application of blends of bitumen with refined coal tar. 
An enhanced level of l-hydroxypyrene in urine of the workers was 
found. 
No significant increase of l-hydroxypyrene in urine of 
workers to diesel exhaust gases were found. It was not clear 
whether this was caused by a low pyrene concentration in diesel 
exhaust gas or by a low airborne concentration of the exhaust 
gas. 
A trace amount of l-hydroxypyrene in urine could be 
detected in referents' urine. A normal value among non-exposed 
referents was determined (median • 0.27 nmol/mmol creatinine, n-
90). The 95-percentile of the reference populations is 
presented as the upper limit of the normal value. The 
l-hydroxypyrene in urine of smoking referents was not 
significantly increased conpared to non-smoking referents 
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(median - 0.28 vs. 0.26 nmol/mmol creatinine). 
The data suggest that urinary 1-hydroxypyrene is a sensitive and 
specific marker for the detection of occupational exposure to 
genotoxic PAH from tarry products. Quantitavive assessment of 
exposure to PAH may be performed on the condition that the 
PAH-profile of the source and the PAH-profile of airborne 
particulates is known. 
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SAMENVATTING VAN HET PROEFSCHRIFT 
" BIOLOGICAL MONITORING OF OCCUPATIONAL EXPOSURE TO PAH n. 
(Een biomedische methode om beroepsmatige blootstelling 
aan PAK te meten). 
Frans Jongeneelen 
De groep PAK (polycyclische aromatische koolwaterstoffen) is een 
groep van chemische stoffen die bij verbrandingsprocessen 
ontstaan en vooral in steenkoolteer en van steenkoolteer 
afgeleide produkten voorkomen. Vele van deze PAK kunnen bij 
proefdieren tumoren doen ontstaan. Daarnaast is gebleken dat 
bepaalde vormen van kanker onder mensen, die beroepsmatig werden 
blootgesteld aan teerdampen, vaker voorkwamen dan onder de 
gehele bevolking. Al met al reden om PAK te beschouwen als een 
mengsel van stoffen met kankerverwekkkende eigenschappen. 
Alleen al in Nederland is het aantal werknemers dat in kontakt 
komt met koolteerprodukten erg groot. Er is geen bevredigende 
methode om blootstelling aan deze stoffen te meten. Het 
directoraat-generaal van de arbeid (DGA) van het Ministerie van 
Sociale Zaken en Werkgelegenheid heeft daarom dit onderzoek 
gesubsidieerd. In het proefschrift wordt de ontwikkeling van 
een methode beschreven om door middel van urine onderzoek 
blootstelling aan PAK te kunnen meten. Met deze biomedische 
methode kon op verschillende werkplekken blootstelling worden 
vastgesteld. 
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De groep van PAK bestaat uit vele tientallen componenten. 
Door verontreiniging van het leefmilieu wordt men via het 
voedsel, drinkwater en de lucht blootgesteld aan geringe 
hoeveelheden PAK. Daarnaast is blootstelling mogelijk door het 
gebruik van teershampoo, door bodemverontreiniging, door 
doe-het-zelf aktiviteiten en dergelijke. Het proefschrift ie 
met name gericht op de meting van beroepsmatige blootstelling 
aan PAK. Zulke metingen zijn nodig om het nivo van 
blootstelling van werknemers in de industrie te kunnen bewaken. 
Vooral bedrijfsartsen en arbeidshygienisten zullen accurate 
meetmethoden goed kunnen gebruiken. 
Het uitgebreide epidemiologisch onderzoek dat werd verricht 
onder werknemers in de gas- en cokesfabrieken, de staalindustrie 
en de aluminiumindustrie van landen als Engeland, Verenigde 
Staten, Japan, etc, heeft duidelijk gemaakt dat koolteerdampen 
en -roet de kans op longkanker bij de mens Akan verhogen. 
De PAK vormen een grote groep van verbindingen waaronder 
een aantal kankerverwekkende. Aangezien zij gezamelijk 
voorkomen, kan de aktiviteit van de afzonderlijke PAK versterkt 
of verzwakt worden door de andere PAK in het mengsel. 
De belangrijkste bron van PAK-verontreiniging in het 
werkmilieu is steenkoolteer en -pek. Steenkoolteer ontstaat als 
bijprodukt bij de verkooksing van steenkool. PAK komen vooral 
voor in koolteer. Door middel van gefractioneerde destillatie 
worden uit koolteer vele produkten gewonnen. Uit de zwaardere 
fracties worden verschillende produkten gefabriceerd zoals 
mastiek, wegenteer, pek, creosootolie, carbolineum, allerlei 
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coatings etc.. Bij de toebereiding en verwerking van deze 
Produkten kunnen werknemers blootgesteld worden aan PAK. 
Het opsporen van blootstelling aan PAK op de werkvloer is 
tot nu toe altijd uitgevoerd door de lucht te bemonsteren. Op 
de werkplekken waar men werkt met teer of van teer gemaakte 
Produkten, is er niet alleen sprake van luchtverontreiniging 
maar vaak is de hele omgeving ook nog verontreinigd met 
neergeslagen teer. PAK kunnen relatief gemakkelijk door de huid 
worden opgenomen. Ook kunnen de PAK via verontreinigde 
werkkleding in kontakt komen met de huid. 
Het PAK-mengsel, zoals dat op de werkplek voorkomt, kan 
meer dan 50 componenten bevatten. Elke component kan in het 
lichaam worden omgezet tot zeer giftige tussenprodukten, die 
voor het overgrote deel weer ontgift worden tot wateroplosbare 
afbraak produkten, die als zodanig uitgescheiden kunnen worden. 
De biomedische meting van blootstelling van een groep stoffen 
als de PAK kan op twee verschillende wijzen uitgevoerd worden. 
Namelijk door middel van een groep-selektieve methode óf door 
middel van een methode die selektief is voor één representatieve 
PAK. Bij de groep-selektieve methode worden alle metabolieten 
met een kenmerkende eigenschap gezamenlijk bepaald. Een 
voorbeeld hiervan is de meting van mutagene1 activiteit van 
omzettingsprodukten van PAK in urine met behulp van een 
Een stof wordt mutageen genoemd wanneer hij in staat is om 
erfelijke eigenschappen te veranderen. Proefondervindelijk is 
een duidelijke samenhang vastgesteld tussen de mutageniteit en 
het vermogen van stoffen om kanker bij proefdieren te 
veroorzaken. 
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bacteciële mutageniteitstest (urine extract in de Ames-test). 
Beroepsmatige blootstelling aan PAK kon echter op deze manier 
niet vastgesteld worden. Hoogstwaarschijnlijk is deze methode 
niet gevoelig genoeg om de uiterst lage blootstelling aan PAK te 
kunnen opsporen. Daarom is het accent meer komen te liggen op 
een methode waarbij een zgn. indicator-PAK wordt gemeten. Uit 
metingen van luchtverontreiniging op verschillende werkplekken 
bleek heel duidelijk dat pyreen een dominante PAK is. Deze 
verbinding hebben we uitgekozen als representant van de hele 
groep van PAK. Door pyreen in reageerbuizen toe te voegen aan 
preparaten van humaan leverweefsel afkomstig van verschillende 
nierdonoren, werd vastgesteld dat pyreen door de mens 
voornamelijk tot hydroxypyreen omgezet wordt. Vervolgens werd 
de representativiteit van deze indicator voor de blootstelling 
aan teer geverifieerd. In hetzelfde testsysteem werd 
vastgesteld dat hydroxypyreen een maat is voor andere, mutagene 
metabolieten, wanneer er sprake is van blootstelling aan teer. 
Bij proefdieren (ratten) kon zelfs na het aanbrengen van 
een kleine hoeveelheid koolteer op de huid, hydroxypyreen worden 
aangetoond in urine. Dit was mogelijk met behulp van een 
chromatografische techniek (HPLC met fluorescentie detektie), na 
enzymatische hydrolyse van hydroxypyreen conjugaten. Ook bleek 
de uitscheiding van hydroxypyreen afhankelijk te zijn van de 
toegediende dosis pyreen. De samenhang tussen hydroxypyreen in 
urine en mutagene metabolieten in urine na blootstelling aan 
teer was erg hoog. 
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Op het moment dat duidelijk werd dat de urine monsters van 
eczeem-patiënten, behandeld met koolteer-preparaten, relatief 
grote hoeveelheden hydroxypyreen bevatte, kreeg het onderzoek 
een belangrijke impuls. Dit was een aanwijzing dat deze 
PAK-metaboliet wellicht ook in de urine van beroepsmatig 
blootgestelden voorkwam. 
Door urinemonsters van ca. 100 personen, die niet via hun 
werk werden blootgesteld te onderzoeken konden referentie 
waarden worden vastgesteld. De urine van deze personen 
vertoonde uiterst lage achtergrondwaarden van hydroxypyreen in 
urine. De gemiddelde waarde van rokers lag iets hoger dan die 
van niet rokende controles, maar dit verschil was niet 
noemenswaardig. De verstorende invloed van rookgewoonten is dus 
zeer beperkt. 
De methode werd vervolgens op bruikbaarheid getoetst in 
verschillende industriële situaties. De eerste was een 
industrie die door middel van een vacuum-druk proces hout 
impregneerde met creosoot. Creosoot is een schimmelwerend 
middel en het bevat PAK. Drie medewerkers van dit bedrijf, nl. 
een machineoperator, een werfmedewerker en een opzichter 
verzamelden gedurende 10 dagen de ochtend en avond urine. Alle 
3 vertoonden ze een sterk verhoogde uitscheiding van 
hydroxypyreen. De uitscheiding vertoonde het ritme van een 
werkweek-weekend, waarbij in de loop van de werkweek een 
ophoping optrad. 
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De methode werd verder geëvalueerd in een steenkoolteer 
verwerkend bedrijf. Bij dit bedrijf werd ruwe koolteer verwerkt 
door middel van gefractioneerde destillatie tot vele Produkten 
als roetolie, elektrodepek, asfaltpek, dakbedekking, creosoot, 
wegenteren, etc. De concentratie hydroxypyreen in urine van de 
werknemers van het bedrijf bleken sterk verhoogd t.o.v. de 
referentie waarden. 
Als derde beroepsmatige blootgestelde groep werden 
asfalteerders in de wegenbouw onder de loep genomen. Het 
onderzoek werd uitgevoerd bij de leden van 10 asfaltploegen die 
teer-asfalt verwerkten. Zij werkten met kleefmiddelen ten 
behoeve van oppervlakte behandelingen of met asfalt waaraan teer 
was toegevoegd. Bij al deze ploegen werden zeer duidelijk 
verhoogde spiegels van hydroxypyreen in urine gevonden. 
De gevoeligheid van de voorgestelde methode is hoog, de 
meting is uit te voeren met apparatuur die tot de normale 
uitrusting van een analytisch chemisch laboratorium behoort. De 
voorgestelde biomedische methode biedt zeer duidelijke 
mogelijkheden om blootstelling aan PAK op te sporen. Op dit 
moment wordt de in het proefschrift voorgestelde biomedische 
bepaling al gebruikt in verschillende Nederlandse en 
buitenlandse laboratoria om blootstelling aan PAK te kunnen 
meten. 
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arithmetic mean 
American Conference of Governmental Industrial 
Hygienists 
aryl hydrocarbon hydroxylase 
benz(a)anthracene 
benzo(a)pyrene 
biological monitoring 
biological effect monitoring 
confidence interval 
confidence limits 
coal tar pitch volatiles 
coefficient of variation 
covalent binding of electrofile compound to DNA 
dimethylsulphoxide 
enzyme linked immuno sorbent assay 
environmental monitoring 
environmental protection agency 
gaschromatograph/mass spectrometer 
geometric mean 
high pressure liquid Chromatograph 
International Agency for Research on Cancer 
Michaelis-Henten constant (apparent affinity) 
maximal allowable concentration 
National Cancer Institute 
National Institute of Occupational Safety 
and Health 
nuclear magnetic resonance 
1-hydroxypyrene 
3-hydroxybenzo(a)pyrene 
polycyclic aromatic compounds 
polycyclic aromatic hydrocarbons 
relative distribution of PAH 
radioimmuno assay 
with octadecanyl modified silica 
statistical analyses system 
sister chromatid exchange 
standard deviation 
standard error of the mean 
9000xg supernatant of tissue homogenate 
diluted S9 with co-factors 
treshold limit value 
time-weighted average 
ultra sensitive enzyme linked 
radioimmuno assay 
maximal initial reaction velocity 
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